BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591-595. [PMID: 19349983 DOI: 10.1038/ng.348] [Cited by in Crossref: 375] [Cited by in F6Publishing: 363] [Article Influence: 28.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhu M, Dai J, Wang C, Wang Y, Qin N, Ma H, Song C, Zhai X, Yang Y, Liu J, Liu L, Li S, Liu J, Yang H, Zhu F, Shi Y, Shen H, Jin G, Zhou W, Hu Z. Fine mapping the MHC region identified four independent variants modifying susceptibility to chronic hepatitis B in Han Chinese. Hum Mol Genet 2016;25:1225-32. [DOI: 10.1093/hmg/ddw003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
2 Laouénan C, Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Abdel-hamid M, Rekacewicz C, Obach D, Fontanet A, Abel L. Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions. Hum Genet 2009;126:697-705. [DOI: 10.1007/s00439-009-0721-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
3 Hoang TV, Toan NL, Song le H, Ouf EA, Bock CT, Kremsner PG, Kun JF, Velavan TP. Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS One 2011;6:e28113. [PMID: 22140517 DOI: 10.1371/journal.pone.0028113] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
4 Kim YJ, Kim HY, Lee J, Yu SJ, Yoon J, Lee H, Kim CY, Cheong JY, Cho SW, Park NH, Park BL, Namgoong S, Kim LH, Cheong HS, Shin HD. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Human Molecular Genetics 2013;22:4233-8. [DOI: 10.1093/hmg/ddt266] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 8.4] [Reference Citation Analysis]
5 Newport MJ, Finan C. Genome-wide association studies and susceptibility to infectious diseases. Brief Funct Genomics 2011;10:98-107. [PMID: 21436306 DOI: 10.1093/bfgp/elq037] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
6 Wu HL, Hsiao TH, Chen PJ, Wong SH, Kao JH, Chen DS, Lu JY, Lu TP, Chen Y, Chuang EY, Tu HC, Liu CJ. Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients. Sci Rep. 2016;6:31349. [PMID: 27546197 DOI: 10.1038/srep31349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
7 Farahani RH, Esmaeilzadeh E, Asl AN, Heidari MF, Hazrati E. Frequency of HLA Alleles in a Group of Severe COVID-19 Iranian Patients. Iran J Public Health 2021;50:1882-6. [PMID: 34722384 DOI: 10.18502/ijph.v50i9.7061] [Reference Citation Analysis]
8 Stättermayer AF, Scherzer T, Beinhardt S, Rutter K, Hofer H, Ferenci P. Review article: genetic factors that modify the outcome of viral hepatitis. Aliment Pharmacol Ther 2014;39:1059-70. [PMID: 24654629 DOI: 10.1111/apt.12717] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
9 Wang LY, Chen CF, Wu TW, Lai SK, Chu CC, Lin HH. Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1. Vaccine 2019;37:6435-40. [PMID: 31515149 DOI: 10.1016/j.vaccine.2019.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Leist SR, Baric RS. Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections. Trends Genet 2018;34:777-89. [PMID: 30131185 DOI: 10.1016/j.tig.2018.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Chen PL, Fann CS, Chu CC, Chang CC, Chang SW, Hsieh HY, Lin M, Yang WS, Chang TC. Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles. PLoS One 2011;6:e16635. [PMID: 21307958 DOI: 10.1371/journal.pone.0016635] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
12 Xu X, Yue M, Jiang L, Deng X, Zhang Y, Zhang Y, Zhu D, Xiao W, Zhou Z, Yao W, Kong J, Yu X, Wei J. Genetic variants in human leukocyte antigen-DP influence both hepatitis C virus persistence and hepatitis C virus F protein generation in the Chinese Han population. Int J Mol Sci 2014;15:9826-43. [PMID: 24897020 DOI: 10.3390/ijms15069826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
13 Maier M, Takano T, Sapir-Pichhadze R. Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine. Can J Kidney Health Dis 2017;4:2054358116688227. [PMID: 28270929 DOI: 10.1177/2054358116688227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
14 Yu F, Zhang X, Tian S, Geng L, Xu W, Ma N, Wang M, Jia Y, Liu X, Ma J, Quan Y, Zhang C, Guo L, An W, Liu D. Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients. Biosci Rep 2017;37:BSR20171263. [PMID: 29138264 DOI: 10.1042/BSR20171263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhong R, Tian Y, Liu L, Qiu Q, Wang Y, Rui R, Yang BF, Duan SY, Shi JX, Miao XP. HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B. PLoS One. 2012;7:e28839. [PMID: 22363396 DOI: 10.1371/journal.pone.0028839] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
16 Yang H, Hung H, Lee M, Liu J, Jen C, Su J, Wang L, Lu S, You S, Iloeje UH, Chen C. Incidence and Determinants of Spontaneous Seroclearance of Hepatitis B e Antigen and DNA in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 2012;10:527-534.e2. [DOI: 10.1016/j.cgh.2011.12.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
17 Zhang Z, Hong Y, Gao J, Xiao S, Ma J, Zhang W, Ren J, Huang L. Genome-wide association study reveals constant and specific loci for hematological traits at three time stages in a White Duroc × Erhualian F2 resource population. PLoS One 2013;8:e63665. [PMID: 23691082 DOI: 10.1371/journal.pone.0063665] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ou G, Liu X, Yang L, Yu H, Ji X, Liu F, Xu H, Qian L, Wang J, Liu Z. Relationship between HLA-DPA1 mRNA expression and susceptibility to hepatitis B. J Viral Hepat 2019;26:155-61. [PMID: 30267609 DOI: 10.1111/jvh.13012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Al-Qahtani AA, Al-Anazi M, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khalaf N, Viswan N, Al-Ahdal MN. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients. Exp Mol Pathol 2013;95:255-8. [PMID: 23994040 DOI: 10.1016/j.yexmp.2013.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
20 O'Brien TR, Yang HI, Groover S, Jeng WJ. Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression. Gastroenterology 2019;156:400-17. [PMID: 30287169 DOI: 10.1053/j.gastro.2018.09.052] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
21 Paramonova N, Trapina I, Dokane K, Kalnina J, Sjakste T, Sjakste N. An Intergenic rs9275596 Polymorphism on Chr. 6p21 Is Associated with Multiple Sclerosis in Latvians. Medicina (Kaunas) 2020;56:E154. [PMID: 32244438 DOI: 10.3390/medicina56040154] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kozuka R, Enomoto M, Sato-Matsubara M, Yoshida K, Motoyama H, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Tamori A, Kawada N, Murakami Y. Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment. J Gastroenterol Hepatol 2019;34:937-46. [PMID: 30160782 DOI: 10.1111/jgh.14454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Song Y, Shen Y, Xia X, Zhang AM. Association between genetic polymorphisms of the IL28B gene and leukomonocyte in Chinese hepatitis B virus-infected individuals. PeerJ 2017;5:e4149. [PMID: 29302390 DOI: 10.7717/peerj.4149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, Zhang XM, Yuan GY, Li CG, Xue LQ, Shen M. A genome-wide association study identifies two new risk loci for Graves’ disease. Nat Genet. 2011;43:897-901. [PMID: 21841780 DOI: 10.1038/ng.898] [Cited by in Crossref: 183] [Cited by in F6Publishing: 167] [Article Influence: 16.6] [Reference Citation Analysis]
25 Wasityastuti W, Yano Y, Ratnasari N, Triyono T, Triwikatmani C, Indrarti F, Heriyanto DS, Yamani LN, Liang Y, Utsumi T. Protective effects of HLA-DPA1/DPB1 variants against Hepatitis B virus infection in an Indonesian population. Infect Genet Evol. 2016;41:177-184. [PMID: 27051043 DOI: 10.1016/j.meegid.2016.03.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
26 Zimmer V, Lammert F. Genetics in liver disease: new concepts. Curr Opin Gastroenterol 2011;27:231-9. [PMID: 21451413 DOI: 10.1097/MOG.0b013e3283444862] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
27 Melum E, Franke A, Karlsen TH. Genome-wide association studies - A summary for the clinical gastroenterologist. World J Gastroenterol 2009; 15(43): 5377-5396 [PMID: 19916168 DOI: 10.3748/wjg.15.5377] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
28 Fu GB, Huang WJ, Zeng M, Zhou X, Wu HP, Liu CC, Wu H, Weng J, Zhang HD, Cai YC, Ashton C, Ding M, Tang D, Zhang BH, Gao Y, Yu WF, Zhai B, He ZY, Wang HY, Yan HX. Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens. Cell Res. 2019;29:8-22. [PMID: 30361550 DOI: 10.1038/s41422-018-0103-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
29 Huang LM, Lu CY, Chen DS. Hepatitis B virus infection, its sequelae, and prevention by vaccination. Curr Opin Immunol. 2011;23:237-243. [PMID: 21257300 DOI: 10.1016/j.coi.2010.12.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
30 Liao Y, Cai B, Li Y, Chen J, Ying B, Tao C, Zhao M, Ba Z, Zhang Z, Wang L. Association of HLA-DP/DQ, STAT4 and IL-28B variants with HBV viral clearance in Tibetans and Uygurs in China. Liver Int. 2015;35:886-896. [PMID: 25041342 DOI: 10.1111/liv.12643] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
31 Kato M, Atsumi T. Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention. Rheumatol Int 2016;36:635-41. [PMID: 26573663 DOI: 10.1007/s00296-015-3395-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Akgöllü E, Bilgin R, Akkız H, Ülger Y, Kaya BY, Karaoğullarından Ü, Arslan YK. Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population. Virus Res 2017;232:6-12. [PMID: 28119119 DOI: 10.1016/j.virusres.2017.01.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
33 Yotsuyanagi H, Ito K, Yamada N, Takahashi H, Okuse C, Yasuda K, Suzuki M, Moriya K, Mizokami M, Miyakawa Y, Koike K. High Levels of Hepatitis B Virus After the Onset of Disease Lead to Chronic Infection in Patients With Acute Hepatitis B. Clinical Infectious Diseases 2013;57:935-42. [DOI: 10.1093/cid/cit348] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
34 Cheong HS, Lee JH, Yu SJ, Yoon JH, Lee HS, Cheong JY, Cho SW, Park NH, Park BL, Namgoong S, Kim LH, Shin HD, Kim YJ. Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population. Liver Int 2015;35:1934-40. [PMID: 25404243 DOI: 10.1111/liv.12740] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
35 Duraisamy GS, Bhosale D, Lipenská I, Huvarova I, Růžek D, Windisch MP, Miller AD. Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going? Viruses 2020;12:E998. [PMID: 32906840 DOI: 10.3390/v12090998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Maurya R, Kanakan A, Vasudevan JS, Chattopadhyay P, Pandey R. Infection outcome needs two to tango: human host and the pathogen. Brief Funct Genomics 2021:elab037. [PMID: 34402498 DOI: 10.1093/bfgp/elab037] [Reference Citation Analysis]
37 Lau KC, Lam CW, Law CY, Lai ST, Tsang TY, Siu CW, To WK, Leung KF, Mak CM, Poon WT. Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment. Clin Chim Acta. 2011;412:952-957. [PMID: 21310144 DOI: 10.1016/j.cca.2011.01.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
38 Tazib T, Kobayashi Y, Ikka T, Zhao CR, Iuchi S, Kobayashi M, Kimura K, Koyama H. Association mapping of cadmium, copper and hydrogen peroxide tolerance of roots and translocation capacities of cadmium and copper in Arabidopsis thaliana. Physiol Plant 2009;137:235-48. [PMID: 19832939 DOI: 10.1111/j.1399-3054.2009.01286.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
39 Liu X, Yu L, Han C, Lu S, Zhu G, Su H, Qin W, Liao X, Peng T. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection. Clin Res Hepatol Gastroenterol 2016;40:739-47. [PMID: 27288300 DOI: 10.1016/j.clinre.2016.04.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
40 Mathew S, Abdel-Hafiz H, Raza A, Fatima K, Qadri I. Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma. World J Hepatol 2016; 8(10): 485-498 [PMID: 27057306 DOI: 10.4254/wjh.v8.i10.485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
41 Simonsen JR, Käräjämäki A, Antikainen AA, Toppila I, Ahlqvist E, Prasad R, Mansour-Aly D, Harjutsalo V, Järvinen A, Tuomi T, Groop L, Forsblom C, Groop PH, Sandholm N, Lehto M. Genetic factors affect the susceptibility to bacterial infections in diabetes. Sci Rep 2021;11:9464. [PMID: 33947878 DOI: 10.1038/s41598-021-88273-w] [Reference Citation Analysis]
42 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
43 Wu T, Chu C, Chang Liao H, Lin S, Ho T, Lin M, Lin HH, Wang L. HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy. Genes Immun 2014;15:47-53. [DOI: 10.1038/gene.2013.62] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
44 Zhu X, Chen L, Fan W, Lin MC, Tian L, Wang M, Lin S, Wang Z, Zhang J, Wang J. An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers. PLoS One. 2011;6:e21997. [PMID: 21779363 DOI: 10.1371/journal.pone.0021997] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
45 Misra MK, Damotte V, Hollenbach JA. The immunogenetics of neurological disease. Immunology 2018;153:399-414. [PMID: 29159928 DOI: 10.1111/imm.12869] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
46 Lemaire D, Barbosa T, Rihet P. Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology. Braz J Med Biol Res 2012;45:376-85. [PMID: 22030866 DOI: 10.1590/s0100-879x2011007500142] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
47 Zhang T, Cai J, Chang J, Yu D, Wu C, Yan T, Zhai K, Bi X, Zhao H, Xu J. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum Mol Genet. 2013;22:1262-1269. [PMID: 23213177 DOI: 10.1093/hmg/dds513] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
48 Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology. 2012;55:1426-1431. [PMID: 22105689 DOI: 10.1002/hep.24799] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 12.3] [Reference Citation Analysis]
49 Xiang X, Guo Y, Yang L, Ge Q, Mijit S, Xu F. Association of human leukocyte antigen DP/DQ gene polymorphisms with chronic hepatitis B in Chinese Han and Uygur populations. Infect Genet Evol 2016;43:407-11. [PMID: 27291710 DOI: 10.1016/j.meegid.2016.06.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Liu L, Li J, Yao J, Yu J, Zhang J, Ning Q, Wen Z, Yang D, He Y, Kong X, Song Q, Chen M, Yang H, Liu Q, Li S, Lin J. A genome-wide association study with DNA pooling identifies the variant rs11866328 in the GRIN2A gene that affects disease progression of chronic HBV infection. Viral Immunol 2011;24:397-402. [PMID: 22004137 DOI: 10.1089/vim.2011.0027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
51 Yano Y, Seo Y, Azuma T, Hayashi Y. Hepatitis B virus and host factors. Hepatobiliary Surg Nutr. 2013;2:121-123. [PMID: 24570927 DOI: 10.3978/j.issn.2304-3881.2012.10.10] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
52 Sun Y, Lu Y, Li T, Xie L, Deng Y, Li S, Qin X. Interferon Gamma +874T/A Polymorphism Increases the Risk of Hepatitis Virus-Related Diseases: Evidence from a Meta-Analysis. PLoS One 2015;10:e0121168. [PMID: 25939029 DOI: 10.1371/journal.pone.0121168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
53 Fernando MM, Freudenberg J, Lee A, Morris DL, Boteva L, Rhodes B, Gonzalez-Escribano MF, Lopez-Nevot MA, Navarra SV, Gregersen PK. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis. 2012;71:777-784. [PMID: 22233601 DOI: 10.1136/annrheumdis-2011-200808] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
54 Wu W, Zeng Y, Lin J, Wu Y, Chen T, Xun Z, Ou Q. Genetic variants in NTCP exon gene are associated with HBV infection status in a Chinese Han population. Hepatol Res 2018;48:364-72. [PMID: 29205714 DOI: 10.1111/hepr.13007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
55 Anczurowski M, Hirano N. Mechanisms of HLA-DP Antigen Processing and Presentation Revisited. Trends Immunol 2018;39:960-4. [PMID: 30416081 DOI: 10.1016/j.it.2018.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
56 Klebanov N. Genetic Predisposition to Infectious Disease. Cureus 2018;10:e3210. [PMID: 30405986 DOI: 10.7759/cureus.3210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
57 Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α. J Gastroenterol Hepatol. 2013;28:861-866. [PMID: 23301835 DOI: 10.1111/jgh.12110] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
58 Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, Tseng HT, Wu D, Lu X, Wang HY, Chen PJ, Chen DS. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA. 2015;112:2175-2180. [PMID: 25646429 DOI: 10.1073/pnas.1424775112] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 15.7] [Reference Citation Analysis]
59 Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun. 2010;11:99-112. [PMID: 19890353 DOI: 10.1038/gene.2009.83] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 6.8] [Reference Citation Analysis]
60 Park GH, Kim KY, Cho SW, Cheong JY, Yu GI, Shin DH, Kwack KB. Association between Interferon-Inducible Protein 6 (IFI6) Polymorphisms and Hepatitis B Virus Clearance. Genomics Inform 2013;11:15-23. [PMID: 23613678 DOI: 10.5808/GI.2013.11.1.15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
61 Galmozzi E, Viganò M, Lampertico P. Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? Aliment Pharmacol Ther. 2014;39:569-578. [PMID: 24461198 DOI: 10.1111/apt.12631] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
62 Ollila HM, Ravel JM, Han F, Faraco J, Lin L, Zheng X, Plazzi G, Dauvilliers Y, Pizza F, Hong SC, Jennum P, Knudsen S, Kornum BR, Dong XS, Yan H, Hong H, Coquillard C, Mahlios J, Jolanki O, Einen M, Arnulf I, Högl B, Frauscher B, Crowe C, Partinen M, Huang YS, Bourgin P, Vaarala O, Désautels A, Montplaisir J, Mack SJ, Mindrinos M, Fernandez-Vina M, Mignot E. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet 2015;96:136-46. [PMID: 25574827 DOI: 10.1016/j.ajhg.2014.12.010] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 12.9] [Reference Citation Analysis]
63 Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H. Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis. Sci Rep. 2016;6:24767. [PMID: 27091392 DOI: 10.1038/srep24767] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
64 Chung S, Roh EY, Park B, Lee Y, Shin S, Yoon JH, Song EY. GWAS identifying HLA-DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA-DPB1*04:02 possessing rs1042169 G - rs9277355 C - rs9277356 A. J Viral Hepat 2019;26:1318-29. [PMID: 31243853 DOI: 10.1111/jvh.13168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Matsuda K. Novel susceptibility loci for hepatocellular carcinoma in chronic HBV carriers. Hepatobiliary Surg Nutr. 2012;1:59-60. [PMID: 24570905 DOI: 10.3978/j.issn.2304-3881.2012.10.17] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
66 Thomas R, Thio CL, Apps R, Qi Y, Gao X, Marti D, Stein JL, Soderberg KA, Moody MA, Goedert JJ. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol. 2012;86:6979-6985. [PMID: 22496224 DOI: 10.1128/jvi.00406-12] [Cited by in Crossref: 109] [Cited by in F6Publishing: 66] [Article Influence: 10.9] [Reference Citation Analysis]
67 Jiang X, Zhang B, Zhao J, Xu Y, Han H, Su K, Tao J, Fan R, Zhao X, Li L, Li MD. Identification and characterization of SEC24D as a susceptibility gene for hepatitis B virus infection. Sci Rep 2019;9:13425. [PMID: 31530870 DOI: 10.1038/s41598-019-49777-8] [Reference Citation Analysis]
68 Huang C, Ge T, Xia C, Zhu W, Xu L, Wang Y, Wu F, Liu F, Zheng M, Chen Z. Association of rs10204525 genotype GG and rs2227982 CC combination in programmed cell death 1 with hepatitis B virus infection risk. Medicine (Baltimore). 2019;98:e16972. [PMID: 31464942 DOI: 10.1097/md.0000000000016972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
69 Liao Y, Cai B, Li Y, Chen J, Tao C, Huang H, Wang L. Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis. PLoS One. 2014;9:e111677. [PMID: 25365208 DOI: 10.1371/journal.pone.0111677] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
70 Tao J, Su K, Yu C, Liu X, Wu W, Xu W, Jiang B, Luo R, Yao J, Zhou J. Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection. Amino Acids. 2015;47:2623-2634. [PMID: 26197724 DOI: 10.1007/s00726-015-2054-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
71 Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet. 2011;20:3893-3898. [PMID: 21764829 DOI: 10.1093/hmg/ddr302] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
72 Isogawa M, Tanaka Y. Immunobiology of hepatitis B virus infection. Hepatol Res. 2015;45:179-189. [PMID: 25331910 DOI: 10.1111/hepr.12439] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
73 Li S, Wang Z, Li Y, Ding G. Adaptive evolution of proteins in hepatitis B virus during divergence of genotypes. Sci Rep 2017;7:1990. [PMID: 28512348 DOI: 10.1038/s41598-017-02012-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
74 Ru Z, Xiao W, Pajot A, Kou Z, Sun S, Maillere B, Zhao G, Ojcius DM, Lone YC, Zhou Y. Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein. PLoS One 2012;7:e32247. [PMID: 22403638 DOI: 10.1371/journal.pone.0032247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
75 Tsutsumi T, Sato H, Kikuchi T, Ikeuchi K, Lim LA, Adachi E, Koga M, Okushin K, Kawahara T, Koibuchi T, Yotsuyanagi H. Factors associated with clearance of hepatitis B virus surface antigen in patients infected with human immunodeficiency virus. Medicine (Baltimore) 2020;99:e21271. [PMID: 32702915 DOI: 10.1097/MD.0000000000021271] [Reference Citation Analysis]
76 Huang J, Xiong L, Wang J, Liu Y, Zhu Q, Lei J, Zhou Z. Association between the HLA-DQB1 polymorphisms and the susceptibility of chronic hepatitis B: A comprehensive meta-analysis. Biomed Rep 2016;4:557-66. [PMID: 27123247 DOI: 10.3892/br.2016.632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
77 Yang YC, Chang TY, Chen TC, Lin WS, Chang SC, Lee YJ. Genetic susceptibility to cervical squamous cell carcinoma is associated with HLA-DPB1 polymorphisms in Taiwanese women. Cancer Immunol Immunother 2015;64:1151-7. [PMID: 26031576 DOI: 10.1007/s00262-015-1721-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
78 Manry J, Quintana-Murci L. A genome-wide perspective of human diversity and its implications in infectious disease. Cold Spring Harb Perspect Med. 2013;3:a012450. [PMID: 23284079 DOI: 10.1101/cshperspect.a012450] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
79 He L, Xu Y, Wang D, Deng Z. Characterization of a novel variant allele HLA-DPA1*02:02:05 , identified in a Chinese Han individual: NEW ALLELE Alerts. Tissue Antigens 2013;81:234-6. [DOI: 10.1111/tan.12066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
80 Nakano R, Maekawa T, Abe H, Hayashida Y, Ochi H, Tsunoda T, Kumada H, Kamatani N, Nakamura Y, Chayama K. Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis C. J Gen Virol 2013;94:81-9. [PMID: 23034592 DOI: 10.1099/vir.0.044396-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
81 Lin CL, Kao JH. New perspectives of biomarkers for the management of chronic hepatitis B. Clin Mol Hepatol. 2016;22:423-431. [PMID: 28081591 DOI: 10.3350/cmh.2016.0069] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
82 Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. J Virol. 2013;87:12176-12186. [PMID: 24006435 DOI: 10.1128/jvi.02073-13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
83 Fan J, Huang X, Chen J, Cai Y, Xiong L, Mu L, Zhou L. Host Genetic Variants in HLA Loci Influence Risk for Hepatitis B Virus Infection in Children. Hepat Mon 2016;16:e37786. [PMID: 27795724 DOI: 10.5812/hepatmon.37786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
84 Jiang DK, Ma XP, Wu X, Peng L, Yin J, Dan Y, Huang HX, Ding DL, Zhang LY, Shi Z. Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis. Sci Rep. 2015;5:16278. [PMID: 26538132 DOI: 10.1038/srep16278] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
85 Karataylı SC, Bozdayı M, Karataylı E, Öztürk T, Husseini AA, Albayrak R, Özkan M, Kalaylıoğlu Z, Yalçın K, Çınar K, İdilman R, Yurdaydın C. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B. Liver Int 2015;35:846-53. [DOI: 10.1111/liv.12595] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
86 Thursz M. Basis of HBV persistence and new treatment options. Hepatol Int. 2014;8 Suppl 2:486-491. [PMID: 26201329 DOI: 10.1007/s12072-013-9504-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
87 Tai DI, Jeng WJ, Lin CY. A global perspective on hepatitis B-related single nucleotide polymorphisms and evolution during human migration. Hepatol Commun. 2017;1:1005-1013. [PMID: 29404438 DOI: 10.1002/hep4.1113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
88 Tan W, Xia J, Dan Y, Li M, Lin S, Pan X, Wang H, Tang Y, Liu N, Tan S, Liu M, He W, Zhang W, Mao Q, Wang Y, Deng G. Genome-wide association study identifies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure. Gut 2018;67:757-66. [PMID: 28130311 DOI: 10.1136/gutjnl-2016-313035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
89 Islam SMS, Kim HA, Choi B, Jung JY, Lee SM, Suh CH, Sohn S. Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behçet's Disease with Arthritis. Int J Mol Sci 2019;20:E5044. [PMID: 31614573 DOI: 10.3390/ijms20205044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
90 Hollenbach JA, Madbouly A, Gragert L, Vierra-Green C, Flesch S, Spellman S, Begovich A, Noreen H, Trachtenberg E, Williams T, Yu N, Shaw B, Fleischhauer K, Fernandez-Vina M, Maiers M. A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. Immunogenetics 2012;64:559-69. [PMID: 22526601 DOI: 10.1007/s00251-012-0615-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
91 Wu Z, Wu Q, Xu J, Chen S, Sun F, Li P, Bai Y, Zheng W, Chen H, Zhang F, Li Y. HLA-DPB1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a Han Chinese population. Int J Rheum Dis 2017;20:1009-15. [DOI: 10.1111/1756-185x.12561] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
92 Mozzi A, Pontremoli C, Sironi M. Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches. Infect Genet Evol 2018;66:286-307. [PMID: 28951201 DOI: 10.1016/j.meegid.2017.09.028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
93 Yang J, Yang Y, Xia M, Wang L, Zhou W, Yang Y, Jiang Y, Wang H, Qian J, Jin L, Wang X. A genetic variant of the NTCP gene is associated with HBV infection status in a Chinese population. BMC Cancer 2016;16:211. [PMID: 26968990 DOI: 10.1186/s12885-016-2257-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
94 Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF. Taiwan consensus statement on the management of chronic hepatitis B. J Formos Med Assoc. 2019;118:7-38. [PMID: 30527436 DOI: 10.1016/j.jfma.2018.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
95 Chen C, Zhu X, Xu W, Yang F, Zhang G, Wu L, Zheng Y, Gao Z, Xie C, Peng L. IFNA2 p.Ala120Thr impairs the inhibitory activity of Interferon-α2 against the hepatitis B virus through altering its binding to the receptor. Antiviral Res 2017;147:11-8. [PMID: 28958921 DOI: 10.1016/j.antiviral.2017.09.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
96 Hsieh AR, Fann CS, Yeh CT, Lin HC, Wan SY, Chen YC, Hsu CL, Tai J, Lin SM, Tai DI. Effects of sex and generation on hepatitis B viral load in families with hepatocellular carcinoma. World J Gastroenterol 2017; 23(5): 876-884 [PMID: 28223732 DOI: 10.3748/wjg.v23.i5.876] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Akgöllü E. Assessment of HLADP gene rs3128917 and rs9380343 polymorphisms in chronic HBV infection. Turk J Gastroenterol 2019;30:616-23. [PMID: 31290749 DOI: 10.5152/tjg.2019.18480] [Reference Citation Analysis]
98 Matzaraki V, Kumar V, Wijmenga C, Zhernakova A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol 2017;18:76. [PMID: 28449694 DOI: 10.1186/s13059-017-1207-1] [Cited by in Crossref: 196] [Cited by in F6Publishing: 165] [Article Influence: 39.2] [Reference Citation Analysis]
99 Morgan LZ, Rollins B, Sequeira A, Byerley W, DeLisi LE, Schatzberg AF, Barchas JD, Myers RM, Watson SJ, Akil H, Bunney WE Jr, Vawter MP. Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders. Microarrays (Basel) 2016;5:6. [PMID: 26998349 DOI: 10.3390/microarrays5010006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
100 Strunk T, Jamieson SE, Burgner D. Genetic and epigenetic susceptibility to early life infection. Curr Opin Infect Dis 2013;26:241-7. [PMID: 23449138 DOI: 10.1097/QCO.0b013e32835fb8d9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
101 Nishida N, Sugiyama M, Sawai H, Nishina S, Sakai A, Ohashi J, Khor SS, Kakisaka K, Tsuchiura T, Hino K, Sumazaki R, Takikawa Y, Murata K, Kanda T, Yokosuka O, Tokunaga K, Mizokami M. Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine. Hepatology 2018;68:848-58. [PMID: 29534301 DOI: 10.1002/hep.29876] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
102 Nishida N, Tokunaga K, Mizokami M. Genome-Wide Association Study Reveals Host Genetic Factors for Liver Diseases. J Clin Transl Hepatol. 2013;1:45-50. [PMID: 26357606 DOI: 10.14218/jcth.2013.010xx] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
103 Brouwer WP, Sonneveld MJ, Tabak F, Simon K, Cakaloglu Y, Akarca US, Zeuzem S, Ferenci P, Heathcote JE, de Knegt RJ, Boonstra A, Hansen BE, Janssen HL. Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B. Aliment Pharmacol Ther 2014;40:811-8. [PMID: 25109699 DOI: 10.1111/apt.12910] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
104 Rao M, Zhenjiang L, Meng Q, Sinclair G, Dodoo E, Maeurer M. Mutant Epitopes in Cancer. In: Zitvogel L, Kroemer G, editors. Oncoimmunology. Cham: Springer International Publishing; 2018. pp. 41-67. [DOI: 10.1007/978-3-319-62431-0_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
105 Li Z, Hou X, Cao G. Is mother-to-infant transmission the most important factor for persistent HBV infection? Emerg Microbes Infect. 2015;4:e30. [PMID: 26060603 DOI: 10.1038/emi.2015.30] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
106 Li X, Liu W, Wang H, Jin X, Fang S, Shi Y, Liu Z, Zhang S, Yang S. The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China. Virus Res. 2012;163:328-333. [PMID: 22056847 DOI: 10.1016/j.virusres.2011.10.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
107 Morishima S, Shiina T, Suzuki S, Ogawa S, Sato-Otsubo A, Kashiwase K, Azuma F, Yabe T, Satake M, Kato S, Kodera Y, Sasazuki T, Morishima Y; Japan Marrow Donor Program. Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation. Blood 2018;131:808-17. [PMID: 29246901 DOI: 10.1182/blood-2017-08-801449] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
108 Okada Y, Uno N, Sato S, Mori S, Sasaki D, Kaku N, Kosai K, Morinaga Y, Hasegawa H, Yanagihara K. Strong influence of human leukocyte antigen-DP variants on response to hepatitis B vaccine in a Japanese population. Vaccine. 2017;35:5662-5665. [PMID: 28882445 DOI: 10.1016/j.vaccine.2017.08.045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
109 Hosaka T, Suzuki F, Kobayashi M, Fukushima T, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy. Liver Int 2015;35:1290-302. [PMID: 25103089 DOI: 10.1111/liv.12652] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
110 He XT, Xu HQ, Wang XM, He XS, Niu JQ, Gao PJ. Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2017; 23(2): 232-241 [PMID: 28127197 DOI: 10.3748/wjg.v23.i2.232] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
111 Xu J, Zhan Q, Fan Y, Yu Y, Zeng Z. Human genetic susceptibility to hepatitis B virus infection. Infect Genet Evol 2021;87:104663. [PMID: 33278635 DOI: 10.1016/j.meegid.2020.104663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 An P, Winkler C, Guan L, O’Brien SJ, Zeng Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J Infect Dis. 2011;203:943-947. [PMID: 21402545 DOI: 10.1093/infdis/jiq154] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
113 Wen J, Song C, Jiang D, Jin T, Dai J, Zhu L, An J, Liu Y, Ma S, Qin N. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study. Sci Rep. 2015;5:16489. [PMID: 26568165 DOI: 10.1038/srep16489] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
114 Czarnecki C, Luo M, Brunham R, Broliden K, Karlsson AC, Plummer FA. Identification of HLA-DPA1*020107 in an individual of Ugandan descent. Human Immunology 2010;71:733-5. [DOI: 10.1016/j.humimm.2010.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
115 Greliche N, Zeller T, Wild PS, Rotival M, Schillert A, Ziegler A, Deloukas P, Erdmann J, Hengstenberg C, Ouwehand WH, Samani NJ, Schunkert H, Munzel T, Lackner KJ, Cambien F, Goodall AH, Tiret L, Blankenberg S, Trégouët DA; Cardiogenics Consortium. Comprehensive exploration of the effects of miRNA SNPs on monocyte gene expression. PLoS One 2012;7:e45863. [PMID: 23029284 DOI: 10.1371/journal.pone.0045863] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
116 Al-Qahtani AA, Al-Anazi MR, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khalaf NZ, Eldali AM, Viswan NA. Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients. PLoS One. 2014;9:e80445. [PMID: 24465366 DOI: 10.1371/journal.pone.0080445] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
117 Mazor R, Addissie S, Jang Y, Tai CH, Rose J, Hakim F, Pastan I. Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin. AAPS J 2017;19:117-29. [PMID: 27796910 DOI: 10.1208/s12248-016-9986-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
118 Zhang G, Wang W, Li S, Yang H, Zhang M, Zhang P, Wen Y, Wu A, Yang L, Zhou B, Chen X. IL6 gene allele-specific C/EBPα-binding activity affects the development of HBV infection through modulation of Th17/Treg balance. Genes Immun 2015;16:528-35. [PMID: 26447433 DOI: 10.1038/gene.2015.40] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
119 O'Brien TR, Prokunina-Olsson L, Donnelly RP. IFN-λ4: the paradoxical new member of the interferon lambda family. J Interferon Cytokine Res 2014;34:829-38. [PMID: 24786669 DOI: 10.1089/jir.2013.0136] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 11.9] [Reference Citation Analysis]
120 Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, Gustavsson I, Feuk L, Magnusson PK, McKay JD, Wilander E. Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst. 2013;105:624-633. [PMID: 23482656 DOI: 10.1093/jnci/djt051] [Cited by in Crossref: 100] [Cited by in F6Publishing: 100] [Article Influence: 11.1] [Reference Citation Analysis]
121 Cox NR, Patel K, Tillmann HL. A Rationalized Approach to the Treatment of Patients Infected with Hepatitis B. Mol Diagn Ther 2014;18:203-12. [DOI: 10.1007/s40291-013-0072-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Furukawa H, Oka S, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Nagai T, Hirohata S, Setoguchi K, Okamoto A, Chiba N, Suematsu E, Miyashita T, Migita K, Suda A, Nagaoka S, Tsuchiya N, Tohma S. Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients. PLoS One 2013;8:e53910. [PMID: 23320107 DOI: 10.1371/journal.pone.0053910] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
123 Grimm D, Thimme R, Blum HE. HBV life cycle and novel drug targets. Hepatol Int 2011;5:644-53. [PMID: 21484123 DOI: 10.1007/s12072-011-9261-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
124 Chu X, Yang M, Song ZJ, Dong Y, Li C, Shen M, Zhu YQ, Song HD, Chen SJ, Chen Z, Huang W. Fine mapping MHC associations in Graves' disease and its clinical subtypes in Han Chinese. J Med Genet 2018;55:685-92. [PMID: 29987165 DOI: 10.1136/jmedgenet-2017-105146] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
125 Shi X, Chi X, Pan Y, Gao Y, Li W, Yang C, Zhong J, Xu D, Zhang M, Minuk G, Jiang J, Niu J. IL28B is associated with outcomes of chronic HBV infection. Yonsei Med J 2015;56:625-33. [PMID: 25837166 DOI: 10.3349/ymj.2015.56.3.625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
126 Song Y, Xia T, Xia X, Zhang AM. Genetic polymorphisms of the HLA-DP and HLA-DQ genes could influence Hepatitis B virus infection in Yunnan population. Immunol Invest 2021;50:47-57. [PMID: 32183599 DOI: 10.1080/08820139.2020.1733010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Wang X, Tang H, Teng M, Li Z, Li J, Fan J, Zhong L, Sun X, Xu J, Chen G, Chen D, Wang Z, Xing T, Zhang J, Huang L, Wang S, Peng X, Qin S, Shi Y, Peng Z. Mapping of hepatic expression quantitative trait loci (eQTLs) in a Han Chinese population. J Med Genet 2014;51:319-26. [PMID: 24665059 DOI: 10.1136/jmedgenet-2013-102045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
128 Zidi I, Laaribi AB, Bortolotti D, Belhadj M, Mehri A, Yahia HB, Babay W, Chaouch H, Zidi N, Letaief A, Yacoub S, Boukadida J, Di Luca D, Hannachi N, Rizzo R. HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients. HLA 2016;87:153-9. [PMID: 26956431 DOI: 10.1111/tan.12767] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
129 Tamori A, Kawada N. HLA class II associated with outcomes of hepatitis B and C infections. World J Gastroenterol 2013; 19(33): 5395-5401 [PMID: 24023482 DOI: 10.3748/wjg.v19.i33.5395] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
130 Kumar V, Kato N, Urabe Y, Takahashi A, Muroyama R, Hosono N, Otsuka M, Tateishi R, Omata M, Nakagawa H, Koike K, Kamatani N, Kubo M, Nakamura Y, Matsuda K. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet. 2011;43:455-458. [PMID: 21499248 DOI: 10.1038/ng.809] [Cited by in Crossref: 258] [Cited by in F6Publishing: 235] [Article Influence: 23.5] [Reference Citation Analysis]
131 Namgoong S, Shin JG, Cheong HS, Kim LH, Kim JO, Seo JY, Shin HD, Kim YJ. Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population. Liver Int 2018;38:1576-82. [PMID: 29283494 DOI: 10.1111/liv.13675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
132 Wang Y, Wan YY. Golgi protein 73, hepatocellular carcinoma and other types of cancers. Liver Res 2020;4:161-7. [PMID: 33343966 DOI: 10.1016/j.livres.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
133 Kapoor R, Kottilil S. Strategies to eliminate HBV infection. Future Virol 2014;9:565-85. [PMID: 25309617 DOI: 10.2217/fvl.14.36] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
134 Romani S, Hosseini SM, Mohebbi SR, Kazemian S, Derakhshani S, Khanyaghma M, Azimzadeh P, Sharifian A, Zali MR. Interleukin-16 gene polymorphisms are considerable host genetic factors for patients’ susceptibility to chronic hepatitis B infection. Hepat Res Treat. 2014;2014:790753. [PMID: 25692036 DOI: 10.1155/2014/790753] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
135 Martchenko M, Candille SI, Tang H, Cohen SN. Human genetic variation altering anthrax toxin sensitivity. Proc Natl Acad Sci U S A 2012;109:2972-7. [PMID: 22315420 DOI: 10.1073/pnas.1121006109] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
136 Clifford RJ, Zhang J, Meerzaman DM, Lyu MS, Hu Y, Cultraro CM, Finney RP, Kelley JM, Efroni S, Greenblum SI. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology. 2010;52:2034-2043. [PMID: 21105107 DOI: 10.1002/hep.23943] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 8.4] [Reference Citation Analysis]
137 Lin YJ, Huang LR, Yang HC, Tzeng HT, Hsu PN, Wu HL, Chen PJ, Chen DS. Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model. Proc Natl Acad Sci USA. 2010;107:9340-9345. [PMID: 20439715 DOI: 10.1073/pnas.1004762107] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
138 Niehrs A, Garcia-Beltran WF, Norman PJ, Watson GM, Hölzemer A, Chapel A, Richert L, Pommerening-Röser A, Körner C, Ozawa M, Martrus G, Rossjohn J, Lee JH, Berry R, Carrington M, Altfeld M. A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44. Nat Immunol 2019;20:1129-37. [PMID: 31358998 DOI: 10.1038/s41590-019-0448-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
139 Wan Z, Lin X, Li T, Zhou A, Yang M, Hu D, Feng L, Peng S, Fan L, Tu S, Bin Zhang, Du Y. Genetic variant in CXCL13 gene is associated with susceptibility to intrauterine infection of hepatitis B virus. Sci Rep 2016;6:26465. [PMID: 27212637 DOI: 10.1038/srep26465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
140 Kim LH, Cheong HS, Namgoong S, Kim JO, Kim JH, Park BL, Cho SW, Park NH, Cheong JY, Koh I. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. Infect Genet Evol. 2015;33:72-76. [PMID: 25913043 DOI: 10.1016/j.meegid.2015.04.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
141 Sundqvist E, Buck D, Warnke C, Albrecht E, Gieger C, Khademi M, Lima Bomfim I, Fogdell-Hahn A, Link J, Alfredsson L. JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants. PLoS Pathog. 2014;10:e1004084. [PMID: 24763718 DOI: 10.1371/journal.ppat.1004084] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
142 Misch EA, Berrington WR, Vary JC Jr, Hawn TR. Leprosy and the human genome. Microbiol Mol Biol Rev 2010;74:589-620. [PMID: 21119019 DOI: 10.1128/MMBR.00025-10] [Cited by in Crossref: 82] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
143 Karlsen TH, Lammert F, Thompson RJ. Genetics of liver disease: From pathophysiology to clinical practice. Journal of Hepatology 2015;62:S6-S14. [DOI: 10.1016/j.jhep.2015.02.025] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
144 Karl JA, Heimbruch KE, Vriezen CE, Mironczuk CJ, Dudley DM, Wiseman RW, O'Connor DH. Survey of major histocompatibility complex class II diversity in pig-tailed macaques. Immunogenetics 2014;66:613-23. [PMID: 25129472 DOI: 10.1007/s00251-014-0797-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
145 Roh EY, Yoon JH, In JW, Lee N, Shin S, Song EY. Association of HLA-DP variants with the responsiveness to Hepatitis B virus vaccination in Korean Infants. Vaccine. 2016;34:2602-2607. [PMID: 27083422 DOI: 10.1016/j.vaccine.2016.03.090] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
146 Matthews PC, Carlson JM, Beloukas A, Malik A, Jooste P, Ogwu A, Shapiro R, Riddell L, Chen F, Luzzi G, Jesuthasan G, Jeffery K, Jojic N, Ndung'u T, Carrington M, Goulder PJ, Geretti AM, Klenerman P. HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults. J Infect Dis 2016;213:1248-52. [PMID: 26655301 DOI: 10.1093/infdis/jiv592] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
147 Wu H, Zhao G, Qian F, Liu K, Xie J, Zhou H, Xu J, Xu Y, Han Y, Xie Q. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B. Liver Int. 2015;35:473-481. [PMID: 24517415 DOI: 10.1111/liv.12491] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
148 Liu X, Wan T, Dang S, Wang D, Jiang C, Su Y, Shen M, Tang X, Li X, Li B, Wen L, Feng Q. HLA-DQB1/DRB1 Alleles Associate with Traditional Chinese Medicine Syndrome of Chronic Hepatitis B: A Potential Predictor of Progression. Biomed Res Int 2019;2019:8146937. [PMID: 31871943 DOI: 10.1155/2019/8146937] [Reference Citation Analysis]
149 Li Y, Si L, Zhai Y, Hu Y, Hu Z, Bei JX, Xie B, Ren Q, Cao P, Yang F, Song Q, Bao Z, Zhang H, Han Y, Wang Z, Chen X, Xia X, Yan H, Wang R, Zhang Y, Gao C, Meng J, Tu X, Liang X, Cui Y, Liu Y, Wu X, Li Z, Wang H, Hu B, He M, Gao Z, Xu X, Ji H, Yu C, Sun Y, Xing B, Yang X, Tan A, Wu C, Jia W, Li S, Zeng YX, Shen H, He F, Mo Z, Zhou G. Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese. Nat Commun. 2016;7:11664. [PMID: 27244555 DOI: 10.1038/ncomms11664] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
150 Wei L, Pavlovic V, Bansal AT, Chen X, Foster GR, He H, Kao JH, Lampertico P, Liaw YF, Motoc A, Papatheodoridis GV, Piratvisuth T, Plesniak R, Wat C. Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B. J Viral Hepat 2019;26:1040-9. [PMID: 30972912 DOI: 10.1111/jvh.13107] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Wu T, Chu C, Ho T, Chang Liao H, Lin S, Lin M, Lin HH, Wang L. Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents. Hum Genet 2013;132:1131-9. [DOI: 10.1007/s00439-013-1320-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
152 Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Infection, Genetics and Evolution 2014;28:201-9. [DOI: 10.1016/j.meegid.2014.09.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
153 Iloeje UH, Yang HI, Chen CJ. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver Int. 2012;32:1333-1341. [PMID: 22510145 DOI: 10.1111/j.1478-3231.2012.02805.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 8.4] [Reference Citation Analysis]
154 Sakai A, Noguchi E, Fukushima T, Tagawa M, Iwabuchi A, Kita M, Kakisaka K, Miyasaka A, Takikawa Y, Sumazaki R. Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response. Vaccine. 2017;35:703-710. [PMID: 28043736 DOI: 10.1016/j.vaccine.2016.08.068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
155 Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP, Tian Y, Li RC, Li Z, Zhu X. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One. 2011;6:e17608. [PMID: 21408128 DOI: 10.1371/journal.pone.0017608] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
156 Howell JA, Visvanathan K, Kowdley K, Mccaughan G, Trautwein C. A novel role for human leukocyte antigen-DP in chronic hepatitis B infection: A genomewide association study. Hepatology 2009;50:647-9. [DOI: 10.1002/hep.23147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
157 Krawczyk M, Müllenbach R, Weber SN, Zimmer V, Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol. 2010;7:669-681. [PMID: 21045792 DOI: 10.1038/nrgastro.2010.170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
158 Lam Y, Wong DK, Seto W, To KK, Hung IF, Fung J, Lai C, Yuen M. HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection: Genetic variants and hepatitis B viral activity. J Gastroenterol Hepatol 2014;29:533-9. [DOI: 10.1111/jgh.12378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
159 Adiguzel Y. Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide. Acta Trop 2021;221:106013. [PMID: 34146538 DOI: 10.1016/j.actatropica.2021.106013] [Reference Citation Analysis]
160 Yano Y, Utsumi T, Lusida MI, Hayashi Y. Hepatitis B virus infection in Indonesia. World J Gastroenterol 2015; 21(38): 10714-10720 [PMID: 26478663 DOI: 10.3748/wjg.v21.i38.10714] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
161 Lambert ND, Haralambieva IH, Kennedy RB, Ovsyannikova IG, Pankratz VS, Poland GA. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination. J Infect Dis 2015;211:898-905. [PMID: 25293367 DOI: 10.1093/infdis/jiu553] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
162 Caillat-zucman S. New insights into the understanding of MHC associations with immune-mediated disorders: MHC-associated immune diseases. HLA 2017;89:3-13. [DOI: 10.1111/tan.12947] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
163 Casper M, Grünhage F, Lammert F. Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark? Hepatology 2011;53:1390-2. [PMID: 21480342 DOI: 10.1002/hep.24241] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
164 Yu L, Cheng YJ, Cheng ML, Yao YM, Zhang Q, Zhao XK, Liu HJ, Hu YX, Mu M, Wang B. Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Sci Rep. 2015;5:14933. [PMID: 26462556 DOI: 10.1038/srep14933] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
165 Zhang Z, Wang C, Liu Z, Zou G, Li J, Lu M. Host Genetic Determinants of Hepatitis B Virus Infection. Front Genet. 2019;10:696. [PMID: 31475028 DOI: 10.3389/fgene.2019.00696] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
166 Ito K, Yoneda M, Sakamoto K, Mizokami M. Virological and Clinical Characteristics of Hepatitis B Virus Genotype A. J Gastroenterol 2018;53:18-26. [PMID: 28687901 DOI: 10.1007/s00535-017-1367-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
167 Karlsson EK, Kwiatkowski DP, Sabeti PC. Natural selection and infectious disease in human populations. Nat Rev Genet 2014;15:379-93. [PMID: 24776769 DOI: 10.1038/nrg3734] [Cited by in Crossref: 239] [Cited by in F6Publishing: 194] [Article Influence: 29.9] [Reference Citation Analysis]
168 Zhao Q, Peng L, Huang W, Li Q, Pei Y, Yuan P, Zheng L, Zhang Y, Deng J, Zhong C, Hu B, Ding H, Fang W, Li R, Liao Q, Lin C, Deng W, Yan H, Hou J, Wu Q, Xu T, Liu J, Hu L, Peng T, Chen S, Lai KN, Yuen MF, Wang Y, Maini MK, Li C, Li M, Wang J, Zhang X, Sham PC, Wang J, Gao ZL, Wang Y. Rare inborn errors associated with chronic hepatitis B virus infection. Hepatology 2012;56:1661-70. [PMID: 22610944 DOI: 10.1002/hep.25850] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
169 Díaz-Peña R, Aransay AM, Bruges-Armas J, López-Vázquez A, Rodríguez-Ezpeleta N, Mendibil I, Sánchez A, Torre-Alonso JC, Bettencourt BF, Mulero J, Collantes E, López-Larrea C. Fine mapping of a major histocompatibility complex in ankylosing spondylitis: association of the HLA-DPA1 and HLA-DPB1 regions. Arthritis Rheum 2011;63:3305-12. [PMID: 21769851 DOI: 10.1002/art.30555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
170 Vieira VC, Soares MA. The role of cytidine deaminases on innate immune responses against human viral infections. Biomed Res Int. 2013;2013:683095. [PMID: 23865062 DOI: 10.1155/2013/683095] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
171 Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology. 2011;53:422-428. [PMID: 21274863 DOI: 10.1002/hep.24048] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 8.6] [Reference Citation Analysis]
172 Khor CC, Hibberd ML. Host-pathogen interactions revealed by human genome-wide surveys. Trends Genet. 2012;28:233-243. [PMID: 22445588 DOI: 10.1016/j.tig.2012.02.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
173 Chen SH, Wu HL, Kao JH, Hwang LH. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors. PLoS One. 2012;7:e36984. [PMID: 22615863 DOI: 10.1371/journal.pone.0036984] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
174 Kuniholm MH, Xie X, Anastos K, Xue X, Reimers L, French AL, Gange SJ, Kassaye SG, Kovacs A, Wang T, Aouizerat BE, Strickler HD. Human leucocyte antigen class I and II imputation in a multiracial population. Int J Immunogenet 2016;43:369-75. [PMID: 27774761 DOI: 10.1111/iji.12292] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
175 Khor CC, Hibberd ML. Revealing the molecular signatures of host-pathogen interactions. Genome Biol 2011;12:229. [PMID: 22011345 DOI: 10.1186/gb-2011-12-10-229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
176 Arayasongsak U, Naka I, Ohashi J, Patarapotikul J, Nuchnoi P, Kalambaheti T, Sa-Ngasang A, Chanama S, Chaorattanakawee S. Genetic association study of interferon lambda 3, CD27, and human leukocyte antigen-DPB1 with dengue severity in Thailand. BMC Infect Dis 2020;20:948. [PMID: 33308178 DOI: 10.1186/s12879-020-05636-w] [Reference Citation Analysis]
177 van Lith M, McEwen-Smith RM, Benham AM. HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM. J Biol Chem 2010;285:40800-8. [PMID: 20959457 DOI: 10.1074/jbc.M110.148155] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
178 Petersdorf EW, O'hUigin C. The MHC in the era of next-generation sequencing: Implications for bridging structure with function. Hum Immunol 2019;80:67-78. [PMID: 30321633 DOI: 10.1016/j.humimm.2018.10.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
179 Zeng Z, Liu H, Xu H, Lu H, Yu Y, Xu X, Yu M, Zhang T, Tian X, Xi H, Guan L, Zhang J, O'Brien SJ; HBVstudy consortium. Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression. BMC Med Genomics 2021;14:84. [PMID: 33736632 DOI: 10.1186/s12920-021-00907-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
180 Paquissi FC. Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis. Front Immunol. 2017;8:1195. [PMID: 29033929 DOI: 10.3389/fimmu.2017.01195] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
181 Li C, Bi X, Huang Y, Zhao J, Li Z, Zhou J, Zhang M, Huang Z, Zhao H, Cai J. Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma. PLoS One 2014;9:e101586. [PMID: 24987808 DOI: 10.1371/journal.pone.0101586] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
182 An P, Zeng Z, Winkler CA. The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression. J Infect Dis 2018;218:1404-10. [PMID: 29905807 DOI: 10.1093/infdis/jiy355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
183 Pan L, Zhang L, Zhang W, Wu X, Li Y, Yan B, Zhu X, Liu X, Yang C, Xu J. A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations. Hum Mol Genet. 2014;23:2210-2219. [PMID: 24282030 DOI: 10.1093/hmg/ddt586] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
184 Mooney M, McWeeney S, Sékaly RP. Systems immunogenetics of vaccines. Semin Immunol 2013;25:124-9. [PMID: 23886894 DOI: 10.1016/j.smim.2013.06.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
185 Ikeda N, Kojima H, Nishikawa M, Hayashi K, Futagami T, Tsujino T, Kusunoki Y, Fujii N, Suegami S, Miyazaki Y, Middleton D, Tanaka H, Saji H. Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens 2015;85:252-9. [PMID: 25789826 DOI: 10.1111/tan.12536] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 11.9] [Reference Citation Analysis]
186 Zhang Y, Li Y, Wu M, Cao P, Liu X, Ren Q, Zhai Y, Xie B, Hu Y, Hu Z, Bei J, Ping J, Liu X, Yu Y, Guo B, Lu H, Liu G, Zhang H, Cui Y, Mo Z, Shen H, Zeng YX, He F, Zhang H, Zhou G. Comprehensive assessment showed no associations of variants at the SLC10A1 locus with susceptibility to persistent HBV infection among Southern Chinese. Sci Rep 2017;7:46490. [PMID: 28429786 DOI: 10.1038/srep46490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
187 Chang SW, Fann CS, Su WH, Wang YC, Weng CC, Yu CJ, Hsu CL, Hsieh AR, Chien RN, Chu CM. A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese. PLoS One. 2014;9:e99724. [PMID: 24940741 DOI: 10.1371/journal.pone.0099724] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
188 Taylor M, Bergemann TL, Hussain A, Thompson PD, Spector L. Transmission of HLA-DP variants from parents to children with B-cell precursor acute lymphoblastic leukemia: log-linear analysis using the case-parent design. Hum Immunol 2011;72:897-903. [PMID: 21645570 DOI: 10.1016/j.humimm.2011.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
189 Cheng HR, Liu CJ, Tseng TC, Su TH, Yang HI, Chen CJ, Kao JH. Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients. PLoS One. 2013;8:e53008. [PMID: 23326374 DOI: 10.1371/journal.pone.0053008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
190 Ou G, Xu H, Yu H, Liu X, Yang L, Ji X, Wang J, Liu Z. The roles of HLA-DQB1 gene polymorphisms in hepatitis B virus infection. J Transl Med 2018;16:362. [PMID: 30563535 DOI: 10.1186/s12967-018-1716-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
191 Anstee QM, Day CP. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10:645-655. [PMID: 24061205 DOI: 10.1038/nrgastro.2013.182] [Cited by in Crossref: 204] [Cited by in F6Publishing: 187] [Article Influence: 22.7] [Reference Citation Analysis]
192 Grossman SR, Andersen KG, Shlyakhter I, Tabrizi S, Winnicki S, Yen A, Park DJ, Griesemer D, Karlsson EK, Wong SH, Cabili M, Adegbola RA, Bamezai RN, Hill AV, Vannberg FO, Rinn JL, Lander ES, Schaffner SF, Sabeti PC; 1000 Genomes Project. Identifying recent adaptations in large-scale genomic data. Cell 2013;152:703-13. [PMID: 23415221 DOI: 10.1016/j.cell.2013.01.035] [Cited by in Crossref: 263] [Cited by in F6Publishing: 218] [Article Influence: 29.2] [Reference Citation Analysis]
193 Hsieh AR, Fann CSJ, Lin HC, Tai J, Hsieh SY, Tai DI. Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families. World J Gastroenterol 2021; 27(37): 6262-6276 [PMID: 34712031 DOI: 10.3748/wjg.v27.i37.6262] [Reference Citation Analysis]
194 Liu L, Yao J, Li J, Zhang J, Yu J, Jiang X, Sun S, Liu Q, Chang Y, He Y, Lin J. Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in Han Chinese population. J Huazhong Univ Sci Technolog Med Sci 2011;31:482. [PMID: 21823009 DOI: 10.1007/s11596-011-0477-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
195 Yamada N, Sugiyama R, Nitta S, Murayama A, Kobayashi M, Okuse C, Suzuki M, Yasuda K, Yotsuyanagi H, Moriya K, Koike K, Wakita T, Kato T. Resistance mutations of hepatitis B virus in entecavir-refractory patients. Hepatol Commun 2017;1:110-21. [PMID: 29404449 DOI: 10.1002/hep4.1022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
196 Ou G, Liu X, Xu H, Ji X, Liu X, Wang J. Variation and expression of HLA-DPB1 gene in HBV infection. Immunogenetics 2021;73:253-61. [PMID: 33710355 DOI: 10.1007/s00251-021-01213-w] [Reference Citation Analysis]
197 Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, Fung J, Lin CK, Huang FY, Lai CL, Yuen MF. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One. 2013;8:e66920. [PMID: 23825586 DOI: 10.1371/journal.pone.0066920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
198 Denzin LK, Khan AA, Virdis F, Wilks J, Kane M, Beilinson HA, Dikiy S, Case LK, Roopenian D, Witkowski M, Chervonsky AV, Golovkina TV. Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob. Immunity 2017;47:310-322.e7. [PMID: 28813660 DOI: 10.1016/j.immuni.2017.07.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
199 Anczurowski M, Yamashita Y, Nakatsugawa M, Ochi T, Kagoya Y, Guo T, Wang CH, Rahman MA, Saso K, Butler MO, Hirano N. Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly. Sci Rep 2018;8:4804. [PMID: 29555965 DOI: 10.1038/s41598-018-22931-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
200 Niehrs A, Altfeld M. Regulation of NK-Cell Function by HLA Class II. Front Cell Infect Microbiol 2020;10:55. [PMID: 32133304 DOI: 10.3389/fcimb.2020.00055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
201 Jiang DK, Ma XP, Yu H, Cao G, Ding DL, Chen H, Huang HX, Gao YZ, Wu XP, Long XD, Zhang H, Zhang Y, Gao Y, Chen TY, Ren WH, Zhang P, Shi Z, Jiang W, Wan B, Saiyin H, Yin J, Zhou YF, Zhai Y, Lu PX, Zhang H, Gu X, Tan A, Wang JB, Zuo XB, Sun LD, Liu JO, Yi Q, Mo Z, Zhou G, Liu Y, Sun J, Shugart YY, Zheng SL, Zhang XJ, Xu J, Yu L. Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B. Hepatology. 2015;62:118-128. [PMID: 25802187 DOI: 10.1002/hep.27794] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
202 Romero-Gomez M, Eslam M, Ruiz A, Maraver M. Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment. Liver Int. 2011;31:443-460. [PMID: 21382156 DOI: 10.1111/j.1478-3231.2011.02449.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
203 Lin CL, Kao JH. Recent advances in the treatment of chronic hepatitis B. Expert Opin Pharmacother. 2011;12:2025-2040. [PMID: 21682661 DOI: 10.1517/14656566.2011.590474] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
204 Vermehren J, Lötsch J, Susser S, Wicker S, Berger A, Zeuzem S, Sarrazin C, Doehring A. A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. PLoS One 2012;7:e32605. [PMID: 22448225 DOI: 10.1371/journal.pone.0032605] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
205 Wen J, Liu Y, Liu J, Liu L, Song C, Han J, Zhu L, Wang C, Chen J, Zhai X. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development. Mol Carcinog. 2015;54:1275-1282. [PMID: 25110835 DOI: 10.1002/mc.22200] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
206 Möller M, de Wit E, Hoal EG. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 2010;58:3-26. [PMID: 19780822 DOI: 10.1111/j.1574-695X.2009.00600.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
207 Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, Hosono N, Takahashi A, Kamatani Y, Miki D, Abe H. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet. 2011;20:3884-3892. [PMID: 21750111 DOI: 10.1093/hmg/ddr301] [Cited by in Crossref: 156] [Cited by in F6Publishing: 155] [Article Influence: 14.2] [Reference Citation Analysis]
208 He LM, Xu YP, Deng ZH, Zhao J. HLA-DPA1*01:11 , a well-documented novel allele identified by sequence-based typing in three Chinese Han individuals: NEW ALLELE Alerts. Tissue Antigens 2013;82:75-7. [DOI: 10.1111/tan.12121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
209 Zhou F, Xu X, Wu S, Cui X, Fan L, Pan W. Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients. PLoS One 2016;11:e0165291. [PMID: 27788190 DOI: 10.1371/journal.pone.0165291] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
210 Hirschfield GM, Chapman RW, Karlsen TH, Lammert F, Lazaridis KN, Mason AL. The genetics of complex cholestatic disorders. Gastroenterology. 2013;144:1357-1374. [PMID: 23583734 DOI: 10.1053/j.gastro.2013.03.053] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 11.0] [Reference Citation Analysis]
211 Hou SH, Hu J, Zhang Y, Li QL, Guo JJ. Effects of interaction between genetic variants in human leukocyte antigen DQ and granulysin genes in Chinese Han subjects infected with hepatitis B virus. Microbiol Immunol. 2015;59:209-218. [PMID: 25644528 DOI: 10.1111/1348-0421.12239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
212 Wu J, Han M, Li J, Yang X, Yang D. Immunopathogenesis of HBV Infection. In: Tang H, editor. Hepatitis B Virus Infection. Singapore: Springer; 2020. pp. 71-107. [DOI: 10.1007/978-981-13-9151-4_4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
213 Huang YH, Liao SF, Khor SS, Lin YJ, Chen HY, Chang YH, Huang YH, Lu SN, Lee HW, Ko WY, Huang C, Liu PC, Chen YJ, Wu PF, Chu HW, Wu PE, Tokunaga K, Shen CY, Lee MH. Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Aliment Pharmacol Ther 2020;52:682-91. [PMID: 32573827 DOI: 10.1111/apt.15887] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
214 Deng Y, Li P, Liu W, Pu R, Yang F, Song J, Yin J, Han X, Li C, Zhao J, Wang H, Cao G. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population. J Viral Hepat 2020;27:1150-61. [PMID: 32568442 DOI: 10.1111/jvh.13353] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Andreatta M, Nielsen M. Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign. Immunology 2012;136:306-11. [PMID: 22352343 DOI: 10.1111/j.1365-2567.2012.03579.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
216 Moudi B, Heidari Z, Mahmoudzadeh-sagheb H. Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection. Infection, Genetics and Evolution 2016;44:94-105. [DOI: 10.1016/j.meegid.2016.06.043] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
217 Posuwan N, Payungporn S, Tangkijvanich P, Ogawa S, Murakami S, Iijima S, Matsuura K, Shinkai N, Watanabe T, Poovorawan Y. Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population. PLoS One. 2014;9:e86007. [PMID: 24465836 DOI: 10.1371/journal.pone.0086007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
218 Nakabayashi K, Tajima A, Yamamoto K, Takahashi A, Hata K, Takashima Y, Koyanagi M, Nakaoka H, Akamizu T, Ishikawa N, Kubota S, Maeda S, Tsunoda T, Kubo M, Kamatani N, Nakamura Y, Sasazuki T, Shirasawa S. Identification of independent risk loci for Graves’ disease within the MHC in the Japanese population. J Hum Genet 2011;56:772-8. [DOI: 10.1038/jhg.2011.99] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
219 Han Y, Gu L, Liu J, Li X, Wang M, Gong Q, Yu D, Yang Z, Zhang D, Yang H, Shen Z, Zhu H, Xie Y, Zhang X. Association of Mutations in Toll-like Receptor 2 Signaling Genes With Fulminant Form of Hepatitis B-Related Acute Liver Failure. J Infect Dis 2017;215:1221-30. [PMID: 28329297 DOI: 10.1093/infdis/jix097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
220 Lee HW, Lee SH, Lee MG, Ahn SH, Chang HY, Han KH. The clinical implication of single nucleotide polymorphisms in deoxycytidine kinase in chronic hepatitis B patients treated with lamivudine. J Med Virol 2016;88:820-7. [PMID: 26400223 DOI: 10.1002/jmv.24393] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
221 Mentzer AJ, O'Connor D, Pollard AJ, Hill AV. Searching for the human genetic factors standing in the way of universally effective vaccines. Philos Trans R Soc Lond B Biol Sci 2015;370:20140341. [PMID: 25964463 DOI: 10.1098/rstb.2014.0341] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
222 Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 2013;158:235-245. [PMID: 23420232 DOI: 10.7326/0003-4819-158-4-201302190-00003] [Cited by in Crossref: 153] [Cited by in F6Publishing: 142] [Article Influence: 17.0] [Reference Citation Analysis]
223 Shugart YY, Wang Y, Jia WH, Zeng YX. GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseases. Chin J Cancer 2011;30:226-30. [PMID: 21439243 DOI: 10.5732/cjc.011.10075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
224 Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, Simon M, Krex D, Arlier Z, Nayak N, Ruigrok YM, Niemelä M, Tajima A, von und zu Fraunberg M, Dóczi T, Wirjatijasa F, Hata A, Blasco J, Oszvald A, Kasuya H, Zilani G, Schoch B, Singh P, Stüer C, Risselada R, Beck J, Sola T, Ricciardi F, Aromaa A, Illig T, Schreiber S, van Duijn CM, van den Berg LH, Perret C, Proust C, Roder C, Ozturk AK, Gaál E, Berg D, Geisen C, Friedrich CM, Summers P, Frangi AF, State MW, Wichmann HE, Breteler MM, Wijmenga C, Mane S, Peltonen L, Elio V, Sturkenboom MC, Lawford P, Byrne J, Macho J, Sandalcioglu EI, Meyer B, Raabe A, Steinmetz H, Rüfenacht D, Jääskeläinen JE, Hernesniemi J, Rinkel GJ, Zembutsu H, Inoue I, Palotie A, Cambien F, Nakamura Y, Lifton RP, Günel M. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010;42:420-5. [PMID: 20364137 DOI: 10.1038/ng.563] [Cited by in Crossref: 212] [Cited by in F6Publishing: 178] [Article Influence: 17.7] [Reference Citation Analysis]
225 Hu Z, Yang J, Xiong G, Shi H, Yuan Y, Fan L, Wang Y. HLA-DPB1 Variant Effect on Hepatitis B Virus Clearance and Liver Cirrhosis Development Among Southwest Chinese Population. Hepat Mon 2014;14:e19747. [PMID: 25337146 DOI: 10.5812/hepatmon.19747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
226 Matsuda H, Hiramatsu K, Akazawa Y, Nosaka T, Saito Y, Ozaki Y, Hayama R, Takahashi K, Naito T, Ofuji K, Ohtani M, Nemoto T, Hida Y, Kimura H, Soya Y, Nakamoto Y. Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents. J Med Virol 2018;90:712-20. [PMID: 29283185 DOI: 10.1002/jmv.25011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
227 O'Connor D, Pollard AJ. Characterizing vaccine responses using host genomic and transcriptomic analysis. Clin Infect Dis 2013;57:860-9. [PMID: 23728145 DOI: 10.1093/cid/cit373] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
228 Li T, Liu F, Zhang L, Ye Q, Fan X, Xue Y, Wang L. Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs. Saudi J Gastroenterol 2018;24:30-6. [PMID: 29451182 DOI: 10.4103/sjg.SJG_228_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Tseng T, Liu C, Chen C, Yang W, Yang H, Su T, Wang C, Kuo SF, Liu C, Chen P, Chen D, Kao J. Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection. Aliment Pharmacol Ther 2015;41:949-60. [DOI: 10.1111/apt.13170] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
230 Nishida N, Ohashi J, Sugiyama M, Tsuchiura T, Yamamoto K, Hino K, Honda M, Kaneko S, Yatsuhashi H, Koike K, Yokosuka O, Tanaka E, Taketomi A, Kurosaki M, Izumi N, Sakamoto N, Eguchi Y, Sasazuki T, Tokunaga K, Mizokami M. Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals. Tissue Antigens 2015;86:406-12. [PMID: 26449183 DOI: 10.1111/tan.12684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
231 Kawashima M, Ohashi J, Nishida N, Tokunaga K. Evolutionary analysis of classical HLA class I and II genes suggests that recent positive selection acted on DPB1*04:01 in Japanese population. PLoS One 2012;7:e46806. [PMID: 23056460 DOI: 10.1371/journal.pone.0046806] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
232 Hu Z, Liu Y, Zhai X, Dai J, Jin G, Wang L, Zhu L, Yang Y, Liu J, Chu M. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat Genet. 2013;45:1499-1503. [PMID: 24162738 DOI: 10.1038/ng.2809] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
233 Tan HL, Zain SM, Eng HS, Mohamed Z, Mahadeva S, Chan WK, Lau PC, Basu RC, Mohamed R. Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease. Hepatol Res 2020;50:947-54. [PMID: 32410320 DOI: 10.1111/hepr.13525] [Reference Citation Analysis]
234 Seto WK, Wong DK, Kopaniszen M, Proitsi P, Sham PC, Hung IF, Fung J, Lai CL, Yuen MF. HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B. Clin Infect Dis. 2013;56:1695-1703. [PMID: 23449268 DOI: 10.1093/cid/cit121] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
235 Irham LM, Wong HS, Perwitasari DA, Chou WH, Yang HI, Chang WC. Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study. Medicine (Baltimore) 2019;98:e17936. [PMID: 31860948 DOI: 10.1097/MD.0000000000017936] [Reference Citation Analysis]
236 Barnes E. Therapeutic vaccines in HBV: lessons from HCV. Med Microbiol Immunol 2015;204:79-86. [PMID: 25573348 DOI: 10.1007/s00430-014-0376-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
237 Honegger JR, Tedesco D, Kohout JA, Prasad MR, Price AA, Lindquist T, Ohmer S, Moore-Clingenpeel M, Grakoui A, Walker CM. Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery. Proc Natl Acad Sci U S A 2016;113:10684-9. [PMID: 27601657 DOI: 10.1073/pnas.1602337113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
238 Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One. 2012;7:e39175. [PMID: 22737229 DOI: 10.1371/journal.pone.0039175] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 10.5] [Reference Citation Analysis]
239 Anczurowski M, Sugata K, Matsunaga Y, Yamashita Y, Wang C, Guo T, Murata K, Saijo H, Kagoya Y, Saso K, Butler MO, Hirano N. Chaperones of the class I peptide-loading complex facilitate the constitutive presentation of endogenous antigens on HLA-DP84GGPM87. Journal of Autoimmunity 2019;102:114-25. [DOI: 10.1016/j.jaut.2019.04.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
240 Ballana E, Esté JA. Insights from host genomics into HIV infection and disease: Identification of host targets for drug development. Antiviral Res 2013;100:473-86. [PMID: 24084487 DOI: 10.1016/j.antiviral.2013.09.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
241 Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P. High HLA-DP Expression and Graft-versus-Host Disease. N Engl J Med 2015;373:599-609. [PMID: 26267621 DOI: 10.1056/NEJMoa1500140] [Cited by in Crossref: 174] [Cited by in F6Publishing: 90] [Article Influence: 24.9] [Reference Citation Analysis]
242 Ma X, Jia C, Fu D, Chu M, Ding X, Wu X, Guo X, Pei J, Bao P, Liang C, Yan P. Analysis of Hematological Traits in Polled Yak by Genome-Wide Association Studies Using Individual SNPs and Haplotypes. Genes (Basel) 2019;10:E463. [PMID: 31212963 DOI: 10.3390/genes10060463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
243 Koukoulioti E, Fischer J, Schott E, Fülöp B, Heyne R, Berg T, van Bömmel F. Association of HLA-DPA1 and HLA-DPB1 polymorphisms with spontaneous HBsAg seroclearance in Caucasians. Liver Int 2019;39:646-54. [PMID: 30471179 DOI: 10.1111/liv.14008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
244 Li Z, Xia Y, Feng LN, Chen JR, Li HM, Cui J, Cai QQ, Sim KS, Nairismägi ML, Laurensia Y, Meah WY, Liu WS, Guo YM, Chen LZ, Feng QS, Pang CP, Chen LJ, Chew SH, Ebstein RP, Foo JN, Liu J, Ha J, Khoo LP, Chin ST, Zeng YX, Aung T, Chowbay B, Diong CP, Zhang F, Liu YH, Tang T, Tao M, Quek R, Mohamad F, Tan SY, Teh BT, Ng SB, Chng WJ, Ong CK, Okada Y, Raychaudhuri S, Lim ST, Tan W, Peng RJ, Khor CC, Bei JX. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Lancet Oncol 2016;17:1240-7. [PMID: 27470079 DOI: 10.1016/S1470-2045(16)30148-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
245 Yao JJ, Yu JL, Li J, Chen M, Yang H, Song QL, Lin JS. Association of a HLA-DP gene polymorphism with progression of HBV infection. Shijie Huaren Xiaohua Zazhi 2013; 21(22): 2206-2211 [DOI: 10.11569/wcjd.v21.i22.2206] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
246 Li X, Zhou TC, Wu CH, Tao LL, Bi R, Chen LJ, Deng DY, Liu C, Otecko NO, Tang Y, Lai X, Zhang L, Wei J. Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, China. Sci Rep 2018;8:869. [PMID: 29343698 DOI: 10.1038/s41598-018-19184-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
247 Kumasaka N, Nakamura Y, Kamatani N. The textile plot: a new linkage disequilibrium display of multiple-single nucleotide polymorphism genotype data. PLoS One 2010;5:e10207. [PMID: 20436909 DOI: 10.1371/journal.pone.0010207] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
248 de Mel S, Soon GS, Mok Y, Chung TH, Jeyasekharan AD, Chng WJ, Ng SB. The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation. Int J Mol Sci 2018;19:E1931. [PMID: 29966370 DOI: 10.3390/ijms19071931] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
249 Wang H, Cao G, Fu J, Lv G. Hepatitis Viruses and Hepatoma. In: Bast RC, Hait WN, Kufe DW, Weichselbaum RR, Holland JF, Croce CM, Piccart-gebart M, Wang H, Hong WK, Pollock RE, editors. Holland-Frei Cancer Medicine. Hoboken: John Wiley & Sons, Inc.; 2016. pp. 1-6. [DOI: 10.1002/9781119000822.hfcm031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
250 Miki D, Ochi H, Hayes CN, Aikata H, Chayama K. Hepatocellular carcinoma: towards personalized medicine. Cancer Sci. 2012;103:846-850. [PMID: 22339805 DOI: 10.1111/j.1349-7006.2012.02242.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
251 Ma MJ, Wang HB, Li H, Yang JH, Yan Y, Xie LP, Qi YC, Li JL, Chen MJ, Liu W, Cao WC. Genetic variants in MARCO are associated with the susceptibility to pulmonary tuberculosis in Chinese Han population. PLoS One 2011;6:e24069. [PMID: 21886847 DOI: 10.1371/journal.pone.0024069] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
252 Lin C, Tseng T, Su T, Liu C, Chen P, Lai M, Chen D, Kao J. Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission. Hepatol Int 2012;6:598-605. [DOI: 10.1007/s12072-011-9297-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
253 Wang D, Xu Y, He L, Deng Z. Characterization of the novel HLA-DPB1*139:01 allele identified by sequence-based typing in a Chinese Han individual. Tissue Antigens 2012;80:197-8. [DOI: 10.1111/j.1399-0039.2012.01896.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
254 Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, Griffioen M, Oudshoorn M, Willemze R, Falkenburg JH. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles. Biol Blood Marrow Transplant 2010;16:1282-92. [PMID: 20350610 DOI: 10.1016/j.bbmt.2010.03.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
255 Lanteri MC, Kaidarova Z, Peterson T, Cate S, Custer B, Wu S, Agapova M, Law JP, Bielawny T, Plummer F, Tobler LH, Loeb M, Busch MP, Bramson J, Luo M, Norris PJ. Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. PLoS One 2011;6:e22948. [PMID: 21829673 DOI: 10.1371/journal.pone.0022948] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
256 Warren RL, Birol I. HLA predictions from the bronchoalveolar lavage fluid and blood samples of eight COVID-19 patients at the pandemic onset. Bioinformatics 2021;36:5271-3. [PMID: 32853340 DOI: 10.1093/bioinformatics/btaa756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
257 Ayo CM, Dalalio MM, Visentainer JE, Reis PG, Sippert EÂ, Jarduli LR, Alves HV, Sell AM. Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes. Biomed Res Int 2013;2013:284729. [PMID: 24069594 DOI: 10.1155/2013/284729] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
258 Voorter CEM, Groeneweg M, Joannis M, Meertens C, Agis F, Tilanus MGJ. Allele and haplotype frequencies of HLA-DPA1 and -DPB1 in the population of Guadeloupe: HLA-DPA1 and -DPB1 in Guadeloupe. Tissue Antigens 2014;83:147-53. [DOI: 10.1111/tan.12271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
259 Song QL, He XX, Yang H, Li J, Chen M, Wang MY, Liu Q, Yu JL, Yao JJ, Liu LF, Sun SZ, Lin JS. Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population. Viral Immunol 2012;25:73-8. [PMID: 22225470 DOI: 10.1089/vim.2011.0053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
260 Nishida N, Sawai H, Kashiwase K, Minami M, Sugiyama M, Seto WK, Yuen MF, Posuwan N, Poovorawan Y, Ahn SH. New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia. PLoS One. 2014;9:e86449. [PMID: 24520320 DOI: 10.1371/journal.pone.0086449] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
261 Huang W, Du L, Tang H. Hepatitis B virus reactivation: overview and management. Future Virology 2021;16:821-35. [DOI: 10.2217/fvl-2021-0275] [Reference Citation Analysis]
262 Al-Qahtani AA, Al-Anazi MR, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khalaf NZ, Viswan NA, Al Ahdal MN. Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients. Liver Int. 2013; Oct 7. [Epub ahead of print]. [PMID: 24118788 DOI: 10.1111/liv.12347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
263 Zhou L, Ren J, Cheng S, Xu H, Chen W, Chen D, Wong VKW, Law BYK, Liu Y, Cai X, Tang H, Yu H, Hu J, Hu Y, Zhou H, Ren F, He L, Hu Z, Jiang H, Xu H, Huang A, Chen J. A Functional Variant in Ubiquitin Conjugating Enzyme E2 L3 Contributes to Hepatitis B Virus Infection and Maintains Covalently Closed Circular DNA Stability by Inducing Degradation of Apolipoprotein B mRNA Editing Enzyme Catalytic Subunit 3A. Hepatology 2019;69:1885-902. [DOI: 10.1002/hep.30497] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
264 Su T, Yang H, Tseng T, Liou J, Liu C, Chen C, Chen P, Chen D, Liu C, Kao J. Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy. The Journal of Infectious Diseases 2018;217:1193-201. [DOI: 10.1093/infdis/jix690] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
265 Kao JH. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Liver Int. 2014;34 Suppl 1:112-119. [PMID: 24373087 DOI: 10.1111/liv.12400] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
266 Lương KVQ, Nguyễn LTH. Theoretical basis of a beneficial role for vitamin D in viral hepatitis. World J Gastroenterol 2012; 18(38): 5338-5350 [PMID: 23082050 DOI: 10.3748/wjg.v18.i38.5338] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
267 Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol. 2011;46:1-8. [PMID: 20812021 DOI: 10.1007/s00535-010-0304-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
268 Xiong S, Zhu D, Liang B, Li M, Pan W, He J, Wang H, Sutter K, Dittmer U, Lu M, Liu D, Yang D, Liu J, Zheng X. Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss. EBioMedicine 2021;69:103464. [PMID: 34233260 DOI: 10.1016/j.ebiom.2021.103464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Klasberg S, Lang K, Günther M, Schober G, Massalski C, Schmidt AH, Lange V, Schöfl G. Patterns of non-ARD variation in more than 300 full-length HLA-DPB1 alleles. Human Immunology 2019;80:44-52. [DOI: 10.1016/j.humimm.2018.05.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
270 Zhang XL, Ni XC, Jia JH, Dong JH, Yu FX, Ma N, Liu XH, Li M, Liu DW. Association of the rs3077 and rs9277535 polymorphisms in HLA-DP with hepatitis B virus infection and spontaneous clearance: a meta-analysis. Scand J Gastroenterol. 2013;48:736-744. [PMID: 23601003 DOI: 10.3109/00365521.2013.787643] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
271 Anstee QM, Daly AK, Day CP. Genetic modifiers of non-alcoholic fatty liver disease progression. Biochim Biophys Acta. 2011;1812:1557-1566. [PMID: 21840395 DOI: 10.1016/j.bbadis.2011.07.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
272 Deng Z, Zhen J, Xu Y, Zhao J. Description of the novel HLA-DPB1*166:01 allele identified by sequence-based typing: NEW ALLELE Alerts. Tissue Antigens 2014;83:298-9. [DOI: 10.1111/tan.12312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
273 Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Amano H, Nagai T, Hirohata S, Setoguchi K, Kono H, Okamoto A, Chiba N, Suematsu E, Katayama M, Migita K, Suda A, Ohno S, Hashimoto H, Takasaki Y, Sumida T, Nagaoka S, Tsuchiya N, Tohma S. Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. PLoS One 2014;9:e87792. [PMID: 24498373 DOI: 10.1371/journal.pone.0087792] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
274 Yamada N, Shigefuku R, Sugiyama R, Kobayashi M, Ikeda H, Takahashi H, Okuse C, Suzuki M, Itoh F, Yotsuyanagi H, Yasuda K, Moriya K, Koike K, Wakita T, Kato T. Acute hepatitis B of genotype H resulting in persistent infection. World J Gastroenterol 2014; 20(11): 3044-3049 [PMID: 24659896 DOI: 10.3748/wjg.v20.i11.3044] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
275 Tillmann HL, Yu MW. IL28B: relevance extended to hepatitis B virus or limited to interferon-based therapies in hepatitis C virus? Liver Int 2011;31:1068-70. [PMID: 22093410 DOI: 10.1111/j.1478-3231.2011.02594.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
276 Li S, Nakaya HI, Kazmin DA, Oh JZ, Pulendran B. Systems biological approaches to measure and understand vaccine immunity in humans. Semin Immunol 2013;25:209-18. [PMID: 23796714 DOI: 10.1016/j.smim.2013.05.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
277 Yang Z, Liu W, Yan T, Liu R. HLA-DPB1 rs9277535 polymorphism is associated with rheumatoid arthritis risk in a Chinese Han population. Aging (Albany NY) 2021;13:11696-704. [PMID: 33875616 DOI: 10.18632/aging.202864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Deng Y, Du Y, Zhang Q, Han X, Cao G. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. Cancer Lett. 2014;343:161-171. [PMID: 24120759 DOI: 10.1016/j.canlet.2013.09.041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
279 Liu L, Zhang J, Lu Y, Fang C, Li S, Lin J. Correlations between ASCC3 Gene Polymorphisms and Chronic Hepatitis B in a Chinese Han Population. PLoS One 2015;10:e0141861. [PMID: 26536629 DOI: 10.1371/journal.pone.0141861] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
280 Wang F, Huang S, Gao R, Zhou Y, Lai C, Li Z, Xian W, Qian X, Huang Y, Tang Q, Liu P, Chen R, Liu R, Li X, Tong X, Zhou X, Bai Y, Duan G, Zhang T, Xu X, Wang J, Yang H, Liu S, He Q, Jin X, Liu L. Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. Cell Discov. 2020;6:83. [PMID: 33298875 DOI: 10.1038/s41421-020-00231-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
281 Wu TW, Chen CF, Lai SK, Lin HH, Chu CC, Wang LY. SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study. J Gastroenterol Hepatol. 2015;30:891-899. [PMID: 25389088 DOI: 10.1111/jgh.12845] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
282 Mardian Y, Yano Y, Wasityastuti W, Ratnasari N, Liang Y, Putri WA, Triyono T, Hayashi Y. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study. Virol J 2017;14:201. [PMID: 29061159 DOI: 10.1186/s12985-017-0865-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
283 Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011;43:321-327. [PMID: 21399633 DOI: 10.1038/ng.787] [Cited by in Crossref: 368] [Cited by in F6Publishing: 338] [Article Influence: 33.5] [Reference Citation Analysis]
284 Cariani E, Villa E, Rota C, Critelli R, Trenti T. Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection. Clin Chem Lab Med. 2011;49:1247-1256. [PMID: 21612542 DOI: 10.1515/cclm.2011.618] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
285 Katrinli S, Enc FY, Ozdil K, Ozturk O, Tuncer I, Doganay GD, Doganay L. Effect of HLA-DPA1 alleles on chronic hepatitis B prognosis and treatment response. North Clin Istanb. 2017;3:168-174. [PMID: 28275747 DOI: 10.14744/nci.2016.27870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
286 Tong HV, Thomas Bock C, Velavan TP. Genetic insights on host and hepatitis B virus in liver diseases. Mutation Research/Reviews in Mutation Research 2014;762:65-75. [DOI: 10.1016/j.mrrev.2014.06.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
287 Jansen L, de Niet A, Stelma F, van Iperen EP, van Dort KA, Plat-sinnige MJT, Takkenberg RB, Chin DJ, Zwinderman A(, Lopatin U, Kootstra NA, Reesink HW. HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels. Journal of Hepatology 2014;61:730-7. [DOI: 10.1016/j.jhep.2014.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
288 Bertoletti A, Gehring AJ. Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control? PLoS Pathog 2013;9:e1003784. [PMID: 24367255 DOI: 10.1371/journal.ppat.1003784] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
289 Hirata M, Kamatani Y, Nagai A, Kiyohara Y, Ninomiya T, Tamakoshi A, Yamagata Z, Kubo M, Muto K, Mushiroda T, Murakami Y, Yuji K, Furukawa Y, Zembutsu H, Tanaka T, Ohnishi Y, Nakamura Y, Matsuda K; BioBank Japan Cooperative Hospital Group. Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases. J Epidemiol 2017;27:S9-S21. [PMID: 28190657 DOI: 10.1016/j.je.2016.12.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 13.2] [Reference Citation Analysis]
290 Soh SE, Ong DQ, Gerez I, Zhang X, Chollate P, Shek LP, Lee BW, Aw M. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010;28:2577-9. [PMID: 20105426 DOI: 10.1016/j.vaccine.2010.01.020] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
291 Zhang J, Zhan W, Yang B, Tian A, Chen L, Liao Y, Wu Y, Cai B, Wang L. Genetic Polymorphisms of rs3077 and rs9277535 in HLA-DP associated with Systemic lupus erythematosus in a Chinese population. Sci Rep 2017;7:39757. [PMID: 28094303 DOI: 10.1038/srep39757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
292 Balagopal A, Thomas DL, Thio CL. IL28B and the control of hepatitis C virus infection. Gastroenterology. 2010;139:1865-1876. [PMID: 20950615 DOI: 10.1053/j.gastro.2010.10.004] [Cited by in Crossref: 179] [Cited by in F6Publishing: 169] [Article Influence: 14.9] [Reference Citation Analysis]
293 Heyn H, Moran S, Hernando-Herraez I, Sayols S, Gomez A, Sandoval J, Monk D, Hata K, Marques-Bonet T, Wang L, Esteller M. DNA methylation contributes to natural human variation. Genome Res 2013;23:1363-72. [PMID: 23908385 DOI: 10.1101/gr.154187.112] [Cited by in Crossref: 265] [Cited by in F6Publishing: 225] [Article Influence: 29.4] [Reference Citation Analysis]
294 Zhang L, Yesupriya A, Chang MH, Teshale E, Teo CG. Apolipoprotein E and protection against hepatitis E viral infection in American non-Hispanic blacks. Hepatology. 2015;62:1346-1352. [PMID: 26096528 DOI: 10.1002/hep.27938] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
295 Okada Y, Momozawa Y, Ashikawa K, Kanai M, Matsuda K, Kamatani Y, Takahashi A, Kubo M. Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese. Nat Genet 2015;47:798-802. [PMID: 26029868 DOI: 10.1038/ng.3310] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
296 Cheng HR, Kao JH, Wu HL, Chen TC, Tseng TC, Liu CH, Su TH, Chen PJ, Chen DS, Liu CJ. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously. Liver Int. 2014;34:e71-e79. [PMID: 24119014 DOI: 10.1111/liv.12324] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
297 Hennig BJ, Hall AJ. Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa. Sci Total Environ 2012;423:202-9. [PMID: 20970823 DOI: 10.1016/j.scitotenv.2010.09.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
298 Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-3360 [PMID: 30122875 DOI: 10.3748/wjg.v24.i30.3347] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
299 Clark A, Gerlach F, Tong Hv, Hoan NX, Song le H, Toan NL, Bock CT, Kremsner PG, Velavan TP. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma. Infect Genet Evol. 2013;18:257-261. [PMID: 23748017 DOI: 10.1016/j.meegid.2013.05.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
300 Lumley SF, McNaughton AL, Klenerman P, Lythgoe KA, Matthews PC. Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen. Front Immunol 2018;9:1561. [PMID: 30061882 DOI: 10.3389/fimmu.2018.01561] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
301 Zimmer V, Lammert F. Role of genetics in diagnosis and therapy of acquired liver disease. Molecular Aspects of Medicine 2014;37:15-34. [DOI: 10.1016/j.mam.2013.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
302 Huang P, Fan H, Tian T, Liao P, Li J, Yu R, Xia X, Feng Y, Wang J, Liu Y, Zhang Y, Yue M. The relationship between human leukocyte antigen-DP/DQ gene polymorphisms and the outcomes of HCV infection in a Chinese population. Virol J 2017;14:235. [PMID: 29212520 DOI: 10.1186/s12985-017-0901-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
303 Li M, Xu Y, Pu K, Fan J, Cheng Z, Chen H, Zhou L. Genetic polymorphisms of chemokine (C-X-C motif) ligand 10 gene associated with hepatitis B virus infection in a Chinese Han population. Int Immunopharmacol 2021;98:107888. [PMID: 34153670 DOI: 10.1016/j.intimp.2021.107888] [Reference Citation Analysis]
304 O’Brien TR, Kohaar I, Pfeiffer RM, Maeder D, Yeager M, Schadt EE, Prokunina-Olsson L. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun. 2011;12:428-433. [PMID: 21346778 DOI: 10.1038/gene.2011.11] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
305 Su M, Chen Z, Zheng J, Chen Y. Genetic variants in class II transactivator are associated with chronic hepatitis B virus infection in the Han Chinese population. Int J Immunogenet 2020;47:435-42. [PMID: 32103629 DOI: 10.1111/iji.12483] [Reference Citation Analysis]
306 Grotto RMT, Santos FM, Picelli N, Silva GF, Ferrasi AC, Sarnighausen VCR, Pardini MIMC. HPA-1a/1b could be considered a molecular predictor of poor prognosis in chronic hepatitis C. Rev Soc Bras Med Trop 2019;52:e20170427. [PMID: 31271612 DOI: 10.1590/0037-8682-0427-2017] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
307 Huang Z, Niu Q, Yang B, Zhang J, Yang M, Xu H, Cai B, Hu J, Wu Y, Wang L. Genetic polymorphism of rs9277535 in HLA-DP associated with rheumatoid arthritis and anti-CCP production in a Chinese population. Clin Rheumatol 2018;37:1799-805. [PMID: 29476350 DOI: 10.1007/s10067-018-4030-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
308 Yu F, Ma N, Zhang X, Tian S, Geng L, Xu W, Wang M, Jia Y, Liu X, Ma J, Quan Y, Zhang C, Guo L, An W, Liu D. Comprehensive investigating of cytokine and receptor related genes variants in patients with chronic hepatitis B virus infection. Cytokine 2018;103:10-4. [PMID: 29287219 DOI: 10.1016/j.cyto.2017.12.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
309 Laidlaw SM, Dustin LB. Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV. Front Immunol 2014;5:545. [PMID: 25400636 DOI: 10.3389/fimmu.2014.00545] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
310 Zeng Z. Human genes involved in hepatitis B virus infection. World J Gastroenterol 2014; 20(24): 7696-7706 [PMID: 24976707 DOI: 10.3748/wjg.v20.i24.7696] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
311 Kikuchi M, Kobayashi K, Nishida N, Sawai H, Sugiyama M, Mizokami M, Tokunaga K, Nakaya A. Genome-wide copy number variation analysis of hepatitis B infection in a Japanese population. Hum Genome Var 2021;8:22. [PMID: 34103483 DOI: 10.1038/s41439-021-00154-w] [Reference Citation Analysis]
312 Lusida MI, Juniastuti, Yano Y. Current hepatitis B virus infection situation in Indonesia and its genetic diversity. World J Gastroenterol 2016; 22(32): 7264-7274 [PMID: 27621573 DOI: 10.3748/wjg.v22.i32.7264] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
313 Trinks J, Nishida N, Hulaniuk ML, Caputo M, Tsuchiura T, Marciano S, Haddad L, Blejer J, Bartoli S, Ameigeiras B. Role of HLA-DP and HLA-DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population. Liver Int. 2017;37:1476-1487. [PMID: 28267888 DOI: 10.1111/liv.13405] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
314 Migita K, Abiru S, Ohtani M, Jiuchi Y, Maeda Y, Bae SK, Bekki S, Hashimoto S, Yesmembetov K, Nagaoka S, Nakamura M, Komori A, Ichikawa T, Nakao K, Yatsuhashi H, Ishibashi H, Yasunami M. HLA-DP gene polymorphisms and hepatitis B infection in the Japanese population. Translational Research 2012;160:443-4. [DOI: 10.1016/j.trsl.2012.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
315 Kumar V, Yi Lo PH, Sawai H, Kato N, Takahashi A, Deng Z, Urabe Y, Mbarek H, Tokunaga K, Tanaka Y. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PLoS One. 2012;7:e44743. [PMID: 23024757 DOI: 10.1371/journal.pone.0044743] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
316 Koh S, Bertoletti A. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response? Med Microbiol Immunol 2015;204:87-94. [PMID: 25511870 DOI: 10.1007/s00430-014-0377-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
317 Peng L, Guo J, Zhang Z, Liu L, Cao Y, Shi H, Wang J, Wang J, Friedman SL, Sninsky JJ. A candidate gene study for the association of host single nucleotide polymorphisms with liver cirrhosis risk in chinese hepatitis B patients. Genet Test Mol Biomarkers 2013;17:681-6. [PMID: 23844940 DOI: 10.1089/gtmb.2013.0058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
318 Yan Z, Tan S, Dan Y, Sun X, Deng G, Wang Y. Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis. Infect Genet Evol. 2012;12:1222-1228. [PMID: 22543033 DOI: 10.1016/j.meegid.2012.03.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
319 Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun. 2010;11:232-238. [PMID: 20237496 DOI: 10.1038/gene.2010.1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
320 Al-Qahtani A, Khalak HG, Alkuraya FS, Al-hamoudi W, Alswat K, Al Balwi MA, Al Abdulkareem I, Sanai FM, Abdo AA. Genome-wide association study of chronic hepatitis B virus infection reveals a novel candidate risk allele on 11q22.3. J Med Genet. 2013;50:725-732. [PMID: 24065354 DOI: 10.1136/jmedgenet-2013-101724] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
321 de Bakker PI, Telenti A. Infectious diseases not immune to genome-wide association. Nat Genet 2010;42:731-2. [PMID: 20802473 DOI: 10.1038/ng0910-731] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
322 Shin JG, Cheong HS, Lee K, Ju BG, Lee JH, Yu SJ, Yoon JH, Cheong JY, Cho SW, Park NH, Namgoong S, Kim LH, Kim YJ, Shin HD. Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population. Liver Int 2017;37:354-61. [PMID: 27596359 DOI: 10.1111/liv.13245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
323 Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ, Li Z, Yang J. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet. 2012;8:e1002791. [PMID: 22807686 DOI: 10.1371/journal.pgen.1002791] [Cited by in Crossref: 128] [Cited by in F6Publishing: 130] [Article Influence: 12.8] [Reference Citation Analysis]
324 Jiang J, Li N, Shen Y, Liu J, Liu L, Du J, Lei Y, Wen Y, Yang L, Guo L, Zhang K, Qiang F, Wang S, Hu Z, Dai M, Shen H. Genetic variants in HLA-DP/DQ contribute to risk of cervical cancer: a two-stage study in Chinese women. Gynecol Oncol 2013;129:401-5. [PMID: 23428460 DOI: 10.1016/j.ygyno.2013.02.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
325 Ezzikouri S, Chihab H, Elhabazi A, Wakrim L, Benjelloun S. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status. BMC Infect Dis 2017;17:99. [PMID: 28125961 DOI: 10.1186/s12879-017-2214-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
326 He D, Tao S, Guo S, Li M, Wu J, Huang H, Guo X, Yan G, Zhu P, Wang Y. Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese. Liver Int 2015;35:1941-9. [PMID: 25469587 DOI: 10.1111/liv.12756] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
327 Oka S, Furukawa H, Kawasaki A, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Ito S, Nakamura T, Saisho K, Katayama M, Tsunoda S, Sano H, Migita K, Suda A, Nagaoka S, Tsuchiya N, Tohma S. Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients. PLoS One 2014;9:e99453. [PMID: 24911054 DOI: 10.1371/journal.pone.0099453] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
328 Ezzikouri S, Benjelloun S, Pineau P. Human genetic variation and the risk of hepatocellular carcinoma development. Hepatol Int 2013;7:820-31. [PMID: 26201919 DOI: 10.1007/s12072-013-9463-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
329 Chapman SJ, Hill AVS. Human genetic susceptibility to infectious disease. Nat Rev Genet 2012;13:175-88. [DOI: 10.1038/nrg3114] [Cited by in Crossref: 302] [Cited by in F6Publishing: 256] [Article Influence: 30.2] [Reference Citation Analysis]
330 Xu W, Liu J. The association between microRNA-323b polymorphism and hepatitis B virus persistent infection - some problems should be addressed. J Viral Hepat 2015;22:625. [PMID: 26037063 DOI: 10.1111/jvh.12417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
331 Yasuno K, Bakırcıoğlu M, Low SK, Bilgüvar K, Gaál E, Ruigrok YM, Niemelä M, Hata A, Bijlenga P, Kasuya H, Jääskeläinen JE, Krex D, Auburger G, Simon M, Krischek B, Ozturk AK, Mane S, Rinkel GJ, Steinmetz H, Hernesniemi J, Schaller K, Zembutsu H, Inoue I, Palotie A, Cambien F, Nakamura Y, Lifton RP, Günel M. Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. Proc Natl Acad Sci U S A 2011;108:19707-12. [PMID: 22106312 DOI: 10.1073/pnas.1117137108] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 6.2] [Reference Citation Analysis]
332 Komatsu H, Murakami J, Inui A, Tsunoda T, Sogo T, Fujisawa T. Association between single-nucleotide polymorphisms and early spontaneous hepatitis B virus e antigen seroconversion in children. BMC Res Notes 2014;7:789. [PMID: 25376093 DOI: 10.1186/1756-0500-7-789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
333 Karlsen TH, Melum E, Franke A. The utility of genome-wide association studies in hepatology. Hepatology 2010;51:1833-42. [PMID: 20232293 DOI: 10.1002/hep.23564] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
334 Shin JG, Cheong HS, Kim JY, Lee JH, Yu SJ, Yoon JH, Cheong JY, Cho SW, Park NH, Namgoong S, Kim LH, Kim YJ, Shin HD. Identification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study. Genes Immun 2019;20:1-9. [PMID: 29238036 DOI: 10.1038/s41435-017-0004-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
335 Tseng TC, Kao JH, Chen DS. Peginterferon α in the treatment of chronic hepatitis B. Expert Opin Biol Ther. 2014;14:995-1006. [PMID: 24738850 DOI: 10.1517/14712598.2014.907784] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
336 Geller G, Dvoskin R, Thio CL, Duggal P, Lewis MH, Bailey TC, Sutherland A, Salmon DA, Kahn JP. Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice. Genome Med 2014;6:106. [PMID: 25593592 DOI: 10.1186/s13073-014-0106-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
337 Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, Hige S, Kang JH, Abe K, Mochida S, Watanabe M, Kurosaki M, Asahina Y, Izumi N, Honda M, Kaneko S, Tanaka E, Matsuura K, Itoh Y, Mita E, Korenaga M, Hino K, Murawaki Y, Hiasa Y, Ide T, Ito K, Sugiyama M, Ahn SH, Han KH, Park JY, Yuen MF, Nakamura Y, Tanaka Y, Mizokami M, Tokunaga K. No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. BMC Med Genet. 2012;13:47. [PMID: 22712471 DOI: 10.1186/1471-2350-13-47] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
338 Lo PH, Urabe Y, Kumar V, Tanikawa C, Koike K, Kato N, Miki D, Chayama K, Kubo M, Nakamura Y, Matsuda K. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk. PLoS One 2013;8:e61279. [PMID: 23593449 DOI: 10.1371/journal.pone.0061279] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
339 Matsuura K, Isogawa M, Tanaka Y. Host genetic variants influencing the clinical course of hepatitis B virus infection. J Med Virol. 2016;88:371-379. [PMID: 26255971 DOI: 10.1002/jmv.24350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
340 Meyer D, C Aguiar VR, Bitarello BD, C Brandt DY, Nunes K. A genomic perspective on HLA evolution. Immunogenetics 2018;70:5-27. [PMID: 28687858 DOI: 10.1007/s00251-017-1017-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 13.8] [Reference Citation Analysis]
341 Li J, Yang D, He Y, Wang M, Wen Z, Liu L, Yao J, Matsuda K, Nakamura Y, Yu J. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One. 2011;6:e24221. [PMID: 21904616 DOI: 10.1371/journal.pone.0024221] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
342 Miki D, Ochi H, Takahashi A, Hayes CN, Urabe Y, Abe H, Kawaoka T, Tsuge M, Hiraga N, Imamura M, Kawakami Y, Aikata H, Takahashi S, Akuta N, Suzuki F, Ikeda K, Kumada H, Karino Y, Toyota J, Tsunoda T, Kubo M, Kamatani N, Nakamura Y, Chayama K. HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study. PLoS One 2013;8:e84226. [PMID: 24376798 DOI: 10.1371/journal.pone.0084226] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
343 Wójtowicz A, Bochud PY. Risk stratification and immunogenetic risk for infections following stem cell transplantation. Virulence 2016;7:917-29. [PMID: 27612400 DOI: 10.1080/21505594.2016.1234566] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
344 Vannberg FO, Chapman SJ, Hill AV. Human genetic susceptibility to intracellular pathogens. Immunol Rev 2011;240:105-16. [PMID: 21349089 DOI: 10.1111/j.1600-065X.2010.00996.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
345 Han J, Chen C, Wang C, Qin N, Huang M, Ma Z, Zhu M, Dai J, Jiang Y, Ma H, Jin G, Shen H, Hu Z. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma. Liver Int 2020;40:2117-27. [PMID: 32574393 DOI: 10.1111/liv.14577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
346 Abel L, Alcaïs A, Schurr E. The dissection of complex susceptibility to infectious disease: bacterial, viral and parasitic infections. Curr Opin Immunol 2014;30:72-8. [PMID: 25083600 DOI: 10.1016/j.coi.2014.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
347 Karrar A, Hariharan S, Fazel Y, Moosvi A, Houry M, Younoszai Z, Jeffers T, Zheng L, Munkhzul O, Hunt S, Monge F, Goodman Z, Younossi ZM. Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease. Medicine (Baltimore) 2019;98:e16704. [PMID: 31393374 DOI: 10.1097/MD.0000000000016704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
348 Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M. A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis. Sci Rep 2018;8:11924. [PMID: 30093645 DOI: 10.1038/s41598-018-30406-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
349 Cheng L, Sun X, Tan S, Tan W, Dan Y, Zhou Y, Mao Q, Deng G. Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients. Hepatol Res. 2014;44:1000-1007. [PMID: 24298935 DOI: 10.1111/hepr.12284] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
350 Möller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Edinb) 2010;90:71-83. [PMID: 20206579 DOI: 10.1016/j.tube.2010.02.002] [Cited by in Crossref: 159] [Cited by in F6Publishing: 146] [Article Influence: 13.3] [Reference Citation Analysis]
351 Tangkijvanich P, Chittmittraprap S, Poovorawan K, Limothai U, Khlaiphuengsin A, Chuaypen N, Wisedopas N, Poovorawan Y. A randomized clinical trial of peginterferon alpha-2b with or without entecavir in patients with HBeAg-negative chronic hepatitis B: Role of host and viral factors associated with treatment response. J Viral Hepat. 2016;23:427-438. [PMID: 26387494 DOI: 10.1111/jvh.12467] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
352 Rehman SU, Rauf M, Abbas Z, Hamed MH, Qadri I. Role of Some Predominant Host Immunomodulators' Single Nucleotide Polymorphisms in Severity of Hepatitis B Virus and Hepatitis C Virus Infection. Viral Immunol 2016;29:536-45. [PMID: 27676210 DOI: 10.1089/vim.2016.0062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
353 Lagou V, Garcia-Perez JE, Smets I, Van Horebeek L, Vandebergh M, Chen L, Mallants K, Prezzemolo T, Hilven K, Humblet-Baron S, Moisse M, Van Damme P, Boeckxstaens G, Bowness P, Dubois B, Dooley J, Liston A, Goris A. Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators. Cell Rep 2018;25:798-810.e6. [PMID: 30332657 DOI: 10.1016/j.celrep.2018.09.048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
354 Qiu B, Jiang W, Olyaee M, Shimura K, Miyakawa A, Hu H, Zhu Y, Tang L. Advances in the genome-wide association study of chronic hepatitis B susceptibility in Asian population. Eur J Med Res. 2017;22:55. [PMID: 29282121 DOI: 10.1186/s40001-017-0288-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
355 Jiang X, Ma Y, Cui W, Li MD. Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes. Amino Acids 2014;46:1819-26. [DOI: 10.1007/s00726-014-1767-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
356 Lai MW, Hsu CW, Lin CL, Chien RN, Lin WR, Chang CS, Liang KH, Yeh CT. Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study. Hepatol Int. 2018;12:456-464. [PMID: 30088198 DOI: 10.1007/s12072-018-9890-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
357 He Y, Cao Z, De Groot AS, Brusic V, Schönbach C, Petrovsky N. Computational vaccinology and the ICoVax 2012 workshop. BMC Bioinformatics 2013;14 Suppl 4:I1. [PMID: 23514034 DOI: 10.1186/1471-2105-14-S4-I1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
358 Jilg N, Chung RT. One more piece in the interleukin 28B gene puzzle? The case of hepatitis B. Hepatology. 2013;57:870-872. [PMID: 22911469 DOI: 10.1002/hep.26026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
359 Greenawalt DM, Dobrin R, Chudin E, Hatoum IJ, Suver C, Beaulaurier J, Zhang B, Castro V, Zhu J, Sieberts SK. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res. 2011;21:1008-1016. [PMID: 21602305 DOI: 10.1101/gr.112821.110] [Cited by in Crossref: 135] [Cited by in F6Publishing: 128] [Article Influence: 12.3] [Reference Citation Analysis]
360 Doganay L, Fejzullahu A, Katrinli S, Enc FY, Ozturk O, Colak Y, Ulasoglu C, Tuncer I, Doganay GD. Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B. World J Gastroenterol 2014; 20(25): 8179-8186 [PMID: 25009391 DOI: 10.3748/wjg.v20.i25.8179] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
361 Hiramatsu K, Matsuda H, Nemoto T, Nosaka T, Saito Y, Naito T, Takahashi K, Ofuji K, Ohtani M, Suto H, Yasuda T, Hida Y, Kimura H, Soya Y, Nakamoto Y. Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C. J Med Virol 2017;89:1574-83. [PMID: 28332201 DOI: 10.1002/jmv.24814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
362 Chen H, Sun J, Zhou B, Peng J, Xie Q, Liang X, Fan R, Conran C, Xu J, Ji Y, Zhang X, Sun L, Jia J, Wang G, Hou J, Jiang DK. A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients. Aliment Pharmacol Ther 2020;51:469-78. [PMID: 31943297 DOI: 10.1111/apt.15624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
363 Fareed M, Afzal M. Single nucleotide polymorphism in genome-wide association of human population: A tool for broad spectrum service. Egyptian Journal of Medical Human Genetics 2013;14:123-34. [DOI: 10.1016/j.ejmhg.2012.08.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
364 Su M, Chen H, Zeng Y, Chen T, Chen J, Jiang L, Liu C, Yang B, Ou Q. Association of Genetic Variation of CIITA and NTCP with Chronic Hepatitis B Virus Infection in Han Chinese Populations. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.33646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
365 Goyal RK, Lee SJ, Wang T, Trucco M, Haagenson M, Spellman SR, Verneris M, Ferrell RE. Novel HLA-DP region susceptibility loci associated with severe acute GvHD. Bone Marrow Transplant 2017;52:95-100. [PMID: 27595289 DOI: 10.1038/bmt.2016.210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]